1. society
2. welfare
3. healthcare

Promising
research
dana farber/Boston CHildren’s
research on paediatric brain
tumours is showing promise
p7
DAY 02
ARAB HEALTH
daily dose
TUESDAY
27 JANUARY 2015
T h e o f f i c i a l da i ly n e w s pa p e r o f t h e ara b h e a lt h e x h i b i t i o n
HH SHEIKH MOHAMMED BIN RASHID AL MAKTOUM
OFFICIALLY INAUGURATES THE 40TH EDITION OF
ARAB HEALTH EXHIBITION & CONGRESS
From the latest technologies
to breakthrough procedures;
Arab Health 2015 showcases
the future of healthcare
A
rab Health Exhibition & Congress was
officially inaugurated yesterday by His
Highness Sheikh Mohammed Bin Rashid
Al Maktoum, UAE Vice President, Prime Minister
and Ruler of Dubai.The event welcomes more than
120,000 attendees for the 40th edition of the show.
HE Eng. Essa Al Maidoor, Director-General of
the Dubai Health Authority (DHA) said: “Arab
Health has seen an exponential growth and we
are pleased to extend our suppor t to this event
year-on-year. At the DHA, we strongly believe
in the impor tance of hosting, suppor ting and
attending such conferences that bring together
pioneers in the field of healthcare and provide
an oppor tunity to discuss the latest advances
in the health sector. At the end of the day,
innovation in the health sector, leads to better
patient outcomes.”
According to Organisers, with the Middle
East healthcare sector continuing to enjoy robust
growth, more companies than ever are exhibiting
at Arab Health this year. With 4,000 exhibiting
companies from across the globe, Arab Health
demonstrates that technological innovation is a key
driver for the current global healthcare industry.
The impressive lineup of exhibitors, new
conferences, and increasing number of trade
visitors and conference delegates demonstrates
Arab Health’s position at the heart of the region’s
healthcare industry, and, the continued expansion
of the UAE healthcare market suggests that there
is no better time or place to host one of the
largest healthcare trade events in the world.
HANDS ON WITH THE FUTURE OF SURGERY
W
e are on the threshold of a major
revolution in surgical care”, explains
Dr Muaaz Tarabichi, Chairman,
Middle East Academy of Otolaryngology and
Consultant, American Hospital – Dubai, UAE.
The Future of Surgery Zone at Arab Health
2015 provides an excellent opportunity for
visitors to ‘peek into the future’ and get hands
on with the devices that are set to revolutionise
surgery and talk one-on-one with the experts
responsible for bringing these advances to
surgical theatres in the region.
Echoing the sentiment that we are on the
threshold of a revolution, Kerstin Eyrich, Marketing
Manager for Cochlear AG stated; “the surgical field
is set to change dramatically over the coming years”.
Where surgery once entailed invasive procedures
with long recovery times, advancements in a variety
of fields such as IT and biological sciences have led
to even complex procedures only requiring small
incisions and minimal recovery time.
New surgical technologies and techniques have
contributed to increases in precision and scale as
well as to improved patient outcomes. Surgeons
are now able to operate on microscopic scale. This
rapid pace of development requires skilled surgeons
who must be trained to perform surgeries
using the latest technological advancements.
The zone features a specialised training
platform for cutting-edge technologies and
revolutionary surgery techniques where
visitors can benefit from hands-on training
from top surgical equipment and services
specialists from companies such as Medtronic,
Karl Storz Endoscope and Johnson&Johnson.
Salim Hammoud, Director of Surgical
Technologies at Medtronic Middle East and
Asia says; “Medtronic is at the forefront of
Continues on page 2
PLEASE VISIT MASIMO
Saeed Hall
M-LNCS™ adult
adhesive sensor
Adult reusable
sensor
Stand S1H50
To learn more, visit
www.masimo.co.uk
© 2014 Masimo. All rights reserved.
iSpO2 Rx is CE Marked. Not available in the US. Allows for use of any
M-LNCS™ sensor, sold seperately. Smart mobile device sold separately.
8631C_Ad_Arab_Health_Daily_Dose_2015_iSpO2_Rx_63x267.indd 1
12/24/14 9:26 AM
ARAB HEALTH daily dose
RESISTANT HYPERTENSION THERAPY AFTER SYMPLICITY HTN-3:
WHERE TO NOW?
Cleveland Clinic’s site PIs reflect on lessons from the
landmark renal denervation trial and the road ahead
By: George Thomas, MD, Staff, Cleveland Clinic Glickman Urological & Kidney Institute and Medhi Shishehbor, MD, Staff, Cleveland Clinic Heart & Vascular Institute
PROCEDURE FAILS TO
SIGNIFICANTLY REDUCE
SYSTOLIC PRESSURE IN
PATIENTS WITH RESISTANT
HYPERTENSION
Full results of the SYMPLICITY HTN-3 trial
presented at the American College of Cardiology
2014 Scientific Sessions underscored what the
many physicians had feared: That renal denervation
may not be a panacea for resistant hypertension
after all.
Hopes were dashed when the principal
investigators announced that after six months,
the mean reduction in systolic blood in patients
randomised to the renal denervation arm was only
2.39mmHg lower than in those randomised to the
sham arm, a difference that was not statistically
significant.
The change in 24-hour ambulatory blood
pressure at six months was equally minimal, with
an insignificant difference of 1.96mmHg in favour of
the procedure arm.
A CONUNDRUM
Renal hypertension is approved in more than 80
countries, with an estimated 10,000 procedures
performed to date. Multiple studies published in
leading journals have shown renal denervation
can produce reductions in systolic blood pressure
as great as 30-40mmHg. Patients enrolled in
SYMPLICITY HTN-3 achieved half that reduction.
While such large drops are considered a favourable
response in patients with a systolic pressure greater
than 160mmHg, the blood pressure in patients who
were not treated fell nearly as much.
Three possible explanations have been proposed.
One is that the participants in the sham arm
became more diligent than usual in taking their antihypertension medications when closely watched.
Two; renal denervation was not accomplished in
all patients. Three; blood pressure responds better
when patients are left on their medical regimen for
long periods of time, rather than changing regimens
more often in hopes of finding a more effective
combination or dose of medications.
Medtronic is convinced renal denervation has
value and intends to continue investigating possible
explanations for why the procedure was largely
ineffective in the SYMPLICITY HTN-3 cohort.
George Thomas, MD, a hypertension specialist
in Cleveland Clinic’s Glickman Urological & Kidney
Institute, adds this advice for the near term: “In the
absence of approved device therapy for resistant
hypertension in the US, we must focus on thorough
evaluation of patients with this diagnosis and find
the appropriate combination of medications to use.”
Cleveland Clinic is a sponsor of Arab Health
2015. Dr Thomas and other Cleveland Clinic
specialists are present at the first annual Gulf
Hypertension Conference, commencing today.
HANDS ON WITH THE FUTURE OF SURGERY
innovation in surgical solutions, and our participation
in the Future of Surgery space is in line with our
commitment to the Middle East region.”
This new training platform allows physicians
and surgeons to employ the latest surgical
innovations in their clinical and daily practice.
According to Kerstin Eyrich, Marketing Manager
for Cochlear AG, “minimal invasive approaches
and robotic solutions support ideal results.”
Therefore, the safety of patients is significantly
improved when medical professionals understand
when, how and where to use the latest medical
technologies, in the most effective way.
The Innovation Hub features expert
seminars on the latest advancements in fields
such as minimally invasive neurosurgery,
orthopaedic and bloodless surgery. In addition,
there is a virtual learning platform where
attendees are able choose the field they would
like to learn about allowing them to employ
technologies that Eyrich says “contribute to
cost-effectiveness, optimised clinical processes
and world-class treatment to provide high
quality service to the community throughout
the Middle East”.
Highlighting the fact that over the course of
Dr Tarabichi’s 25-year career there have been
a great deal of changes in the technology and
tools used in operating theatres, the Future
of Surgery Zone features an exhibition on
surgery through the ages, which shows how
the medical discoveries of our ancestors have
affected the way we practice surgery today,
which, as Dr Tarabichi points out, has its roots
in Egypt with “many of the roots of surgical
care [being] laid out by Arab physicians”. In
addition to the historical display, there is the
opportunity for attendees to view a rare 1867
edition of The Lancet containing pioneering
reports by ‘father of modern surgery’ Joseph
Lister, which will be donated to the Al
Maktoum Medical Library during Arab Health.
The Future of Surgery Zone provides a
setting for doctors and healthcare professionals
to get hands on with the latest innovations
that will contribute to an increase in efficiency,
minimally invasive procedures, reduced
recovery time for patients and, crucially for a
region suffering from a shortage of hospital
bed spaces, shorter stays for patients.
AT THE SHOW
Find the Future of Surgery Zone in the Plaza
Hall. Attendance is free
US Pavilion at Arab Health 2015 ribbon cutting ceremony with the Honourbale Barbara A. Leaf, the new US Ambassador to the UAE.
Vu LED SURGICAL LIGHT
Visit us at Booth 4B05
CROSS FOCUS
TECHNOLOGY (CFT)
enables the LED’s to move independently
of each other while adjusting the pattern
size. CFT allows the Vu to provide consistent
output on both the large and small patterns.
2
NUVO-strip ad-horiz.indd 1
facebook.com/arabhealth
A member of the
Medical Illumination International Group
V Series
Surgical Tables
VistOR MS LED
120,000 lux
Navigator Equipment
Management
5368 Kuhl Road • Erie, PA 16510-4703
(814) 899-4220 • Fax: (814) 899-1410
(800) 663-1152
www.nuvosurgical.com
12/9/14 12:52 PM
TUESDAY 27 January 2015
Today at a glance
Arab Health Daily Dose
The Arab Health Daily Dose is the official newspaper of the
Arab Health Exhibition & Congress. Distributed Monday 26
January-Thursday 29 January 2015.
Arab Health 2015 Congress
Conference
ROOM
Location
Start Time
Finish
Total Radiology
Al Multaqua Ballroom
Between Halls 4 & 5
09.00
17.30
Molecular Diagnosis (Medlab)
Sk Maktoum Hall - Part B\C
Shk Maktoum Hall
10.00
17.00
Diabetes
Shk Rashid Hall - Part C
Shk Rashid Hall
09.00
17.00
Paediatrics
Shk Rashid Hall - Part D
Shk Rashid Hall
09.00
16.45
Hypertension
Ajman D/Fujairah A
Above Hall 7
08.15
16.45
Public Health
Dubai C&D
Above Shk Maktoum Hall
09.00
16.00
Urology
Abu Dhabi A
First floor opposite Hall 5
10.00
16.30
Quality Mgmt
Abu Dhabi B
First floor opposite Hall 5
10.00
17.30
Orthopaedics
Al Ain J & K
Above Hall 4
08.00
18.00
Surgery
Umm Al Qwain
Second floor opposite Hall 5
08.50
DIRECTOR - PUBLICATIONS
Joseph Chackola [email protected]
EDITOR
Elin Boyd [email protected]
SALES MANAGER - PRINT & ONLINE
Waseem Ashraf [email protected]
SENIOR GRAPHIC DESIGNER
Mark Walls [email protected]
PRINTED BY
Zabeel Printing Press www.zppdubai.ae
The Arab Health Daily Dose is owned and distributed by Informa Exhibition
Life Sciences, Floor 19, World Trade Centre Tower, Dubai, UAE.
All images © Shutterstock.com unless otherwise specified.
This publication may not be reproduced or transmitted in any form in whole
or part without the written consent of the owners.
For more information on Informa Exhibitions Life Sciences publications, please
visit www.arabhealthmagazine.com
17.15
To s
pea
MEDIA
k th
e
dur
Hea
ing team
thelth, vi Arab
s
loc press it us
i
a
C, a ted inofficen
bov
A
e Ha l Ain
ll 3
18.00 Arab Health Innovation & Achievement Awards
Venue: Bubble Lounge, Dubai International Convention & Exhibition Centre
The Award ceremony is by invitation only.
Download the free Arab Health
mobile app
DOWNLOAD NOW
arabhealthonline.com/mobileapp
FUTURE OF SURGERY
Arab Health 2015 is featuring the newly launched Future of Surgery Zone, a designated area where top
specialists in the healthcare sector showcase the very latest surgical technology and techniques on the most
sophisticated and up-to-date devices and technology. The Future of Surgery Zone is free to attend.
Visit the Future of Surgery Zone in Plaza Hall every day during Arab Health
HIGHLIGHTS
DAY 2 programme
 Innovation hub seminars (see schedule)
 Interactive touchscreen displays to plan
your Future of Surgery experience
 A rare 1867 edition of medical journal,
The Lancet
 A glance at the history of surgery
M
eet one on one with experts in the field
 See the 3D printed baby heart that
allowed doctors from New YorkPresbyterian Morgan Stanley’s Children’s
Hospital better plan ahead of surgery
on a very complex and unique heart
malformation
TIME
COMPANY
TOPIC
TIME
COMPANY
TOPIC
11.00
DePuy Joints
Stability in motion
14.30
Health Economics
11.30
NYP
3D printing of the heart: Model for
surgical planning
Healthcare indicators adjustment for
the GCC population
15.00
NYP
Robotic Prostatectomy
12.00
Primal Pictures
3D human anatomy in real life
15.30
Ethicon Biosurgery
Advances in surgical haemostasis
12.30
Ethicon Sutures
Latest innovation in wound closure STRATAFIX
16.00
NYP
Faecal incontinence and sacral nerve
stimulation
13.00
NYP
Minimally invasive neurosurgery
16.30
NYP
13.30
Primal Pictures
Orthopaedic surgery; a 3D resource
for a 3D subject
Combined Endo-Laparoscopic Surgery
(CELS)
17.00
NYP
Transanal Endoscopic Microsurgery
14.00
Ethicon Bariatric
Science of tissue management bariatric procedures
17.30
NYP
Strategies of the recurrance of Crohn’s
Disease
SELFIE
COMPETITION
WIN
a Samsung
Tweet your selfie to @arab_health
along with #arabhealth
Galaxy Tab3
Upload your images at
arabhealthonline.com/competition
#arabhealth
@arab_health
3
ARAB HEALTH daily dose
GCC HEALTHCARE SPENDING EXPECTED
TO GROW 11.4% FROM 2010-2015: EY
T
he healthcare industry in the GCC
is expected to continue its robust
growth propelled by demographic and
macroeconomic factors in the region. GCC
healthcare spending is expected to increase by a
CAGR of 11.4% from 2010-2015.
The main growth drivers of the industry
include the region’s fast growing population, rising
income levels, increased prevalence of lifestyle
diseases, growing demand for quality healthcare and
mandatory health insurance policies.
GCC governments are trying to make significant
investments to support healthcare provision and
help the industry to grow to international standards.
Several GCC nations have announced plans to
ramp up infrastructure to cater to rising demand,
with major healthcare projects across the region
being planned to accommodate the ever-growing
demand. Even though GCC governments continue
to lead in healthcare expenditure, increased
participation by private players has been seen in the
GCC healthcare industry.
Andrea Longhi, MENA Advisory Healthcare
Leader, EY, said: “The healthcare industry is driven by
positive growth prospects and increased purchasing
power.The growing demand for healthcare services
coupled with regulatory changes and emphasis on
quality healthcare makes the GCC an important
destination for both domestic and international
investors. Healthcare spending in the region has
witnessed significant growth over the past few years
and we expect the growth to continue in the future
with the higher incidence of lifestyle diseases and an
increasing amount of GCC governments enforcing
mandatory medical insurance. “
PRIVATE SECTOR
INVOLVEMENT
With programmes such as mandatory insurance
there is an increasing reliance on the private
healthcare sector and most well established facilities
are focusing to expand rapidly to create capacity for
their growing markets. One way of doing this is by
way of an IPO and raising capital for expansion. The
recent IPO of several healthcare facilities have set
a precedent and more are to follow in the coming
years. Not only this, numerous new facilities are
planned in almost all GCC countries.
Imad U Bokhari, MENA Transaction Advisory
Services Healthcare Leader EY, said: “Healthcare in
general is now a major topic for private investors, as
it weathered the recent financial crisis.The inclusion
of this sector as part of the overall investment
strategy for major institutions has become vital.
We are at the dawn of a major expansion in the
healthcare sector in the region, even if only few of
the many planned facilities come to fruition. Some
of these healthcare developments are so large that
they can only be called medical cities.These promise
to bring more successful medical treatments, worldclass healthcare education, significantly experienced
human capital and some concepts that are entirely
new to the region.”
CHALLENGES
Despite the fast growth of the industry as well as
the increasing demand, there are challenges facing
the GCC healthcare sector. Considerable shortage
of local physicians and qualified allied healthcare
staff in the region poses an obstacle to the industry’s
growth as GCC countries are heavily depending on
expatriates for healthcare workforce.
Healthcare expenditure in the region as a
percentage of the gross domestic product (GDP)
still remains low, despite the considerable healthcare
spending that was witnessed over the past few
years. Healthcare infrastructure in the GCC also
continues to lag international standards, which
restrains the market from expanding, given GCC‘s
strong demand and high income per capita.
“The region will need to invest in training their
local talent to help build a larger pool of physicians
to cater to the growing demand. As the GCC
Governments continue to invest in healthcare, we
should see health expenditure as a percentage of
GDP increase in the future. The new healthcare
projects will help to attract people to the region as a
medical tourism destination. Additionally, establishing
research and clinical trial centres will have significant
impact on retention of talent,” concluded Imad.
RARE GLIMPSE OF THE PAST WILL ILLUMINATE ‘FUTURE OF SURGERY’ AT ARAB HEALTH 2015
US Pavilion organiser to present 1867 volume of The Lancet documenting intro of ‘sterile surgery’ for
event display and region’s permanent collection
I
n a gesture of professional partnership,
and recognition of the 40th anniversary of
the Arab Health Exhibition and Congress,
US International Pavilion organiser Kallman
Worldwide have presented rare bound
copies of the 1867 volume of The Lancet for
the permanent collection of the Al Maktoum
Medical Library in Dubai.
The two-volume set documents the stateof-the-art in medicine 148 years ago, most
notably Dr Joseph Lister’s breakthrough case for
sterile surgery, a discovery that revolutionised
operating theatre procedures and dramatically
reduced the risk of post-operative infection.
The Lister report is prominently displayed for
visitors to the Arab Health ‘Future of Surgery
Zone’, a new interactive exhibition area. After
the event, the bound volumes will be moved to
the permanent collection of the Al Maktoum
Medical Library, part of the Mohammed bin
Rashid Academic Medical Center.
“Arab Health has grown for 40 years because
we share the vision of the global healthcare
industry to protect the integrity of science and
promote relationships among professionals who
work to apply scientific discovery to improve
human health,” said Simon Page, Managing
Director for Life Sciences at Informa Middle East,
the organisers of Arab Health. “The generous gift
of historic documents from Kallman Worldwide
and the US Pavilion recognises the healthcare
community’s value for lifelong learning and Arab
Health’s ongoing support of medical education
here in the Middle East.”
Kallman Worldwide has been organising the
official US Pavilion at Arab Health since 1995.
This year, 268 U.S. companies are exhibiting
with Kallman to present the latest American
medical technologies, solutions and services
to the region’s healthcare decision-makers and
influencers.
Tom Kallman, President and CEO, Kallman
Worldwide said “On behalf of all of our
exhibitors and partners, Kallman Worldwide is
honoured to celebrate our 20th year hosting the
US Pavilion at Arab Health in 2015, and proud
to contribute this historic volume of The Lancet,
one of the world’s oldest and most respected
professional journals, to commemorate the
growing impact of this world-class event and
underscore our support of the Mohammed bin
Rashid Academic Medical Center.”
Visit the UK Pavilions
for the best in Medical Technologies
Zabeel Hall UK Medical Technologies Pavilion | Sheikh Rashid Hall UK Laboratory Technologies Pavilion
Don’t miss the UK Pavilion Surgical Simulation Demonstrations
Visit the ABHI Stand Z1D30
4
3828 ABHI Strip Ad 63x267.indd 1
facebook.com/arabhealth
19/01/2015 12:33
TUESDAY 27 January 2015
UAE’S EVER CHANGING HEALTHCARE LANDSCAPE
THE PLAYERS GIVE THEIR TAKE
T
By: Zeina Khaddaj, Consultant, Shane Phillips Consultants, Dubai, UAE
he population of the UAE has more
than doubled in 2005-2014, putting an
increasing demand on infrastructure and
critical services like education and healthcare. With
hospitals sprouting up like mushrooms, the region
is set to double the number of healthcare facilities
in the region over the next ten years. To find out
what the key challenges are, I spoke with Mariano
Gonzales, Managing Director UAE for Moorfields,
David Hadley, the CEO of Mediclinic, and Alisha
Moopen, Director of Aster DM Healthcare.
The UAE has met the increase in new hospitals,
new providers and a freshly minted eclectic mix
of international healthcare brands with new
regulations and policies.
“One of the biggest challenges the healthcare
industry is facing is the implementation of a
mandatory health insurance scheme, that will have
an impact on the structure and the capability of the
hospital to manage its full resources”, says Gonzales
of Moorfields Eye Hospital. While mandatory health
insurance may sound like a growth catalyst for
the industry, some high quality providers see it as
assisting only the bottom end of the market and
perhaps even making things more challenging for
the premium segment.
David Hadley, CEO of Mediclinic, feels the new
regulations are definitely creating a shift; “I think
first of all; you must realise the impact it has on the
employer side. As an employer, you now need to
provide medical insurance to your staff, which will
drive up your fixed cost, which in turn means that
most facilities will increase their prices, as they can’t
just absorb this cost, causing an inflationary effect
on the whole industry. The ceiling on the insurance
coverage determined by the Health Authority, which
caps the amount insurance companies will cover for
services, compounds the effect. This is happening
in a market that is still developing its tertiary care
facilities, and specialist doctors are expensive. We
are required to attract the best talent while our fees
Zeina Khaddaj, Shane Philips Consultants
are capped” , says Hadley.
“And of course the new patients coming into
the system under the new regulations are those
that cannot cover the difference in the bill after the
insurance pays; hence, those patients will need to
use the low-cost providers, or they will continue
to use the government facilities. So, the private
hospitals that are focused on delivering the highest
quality service and have medium to high prices will
get no additional patients because of the mandatory
health insurance. Rather it will impact us on a cost
side, as well as a revenue side”, says Hadley.
Many feel the new system seems to benefit
insurance providers the most, providing little
advantage to those healthcare providers who
are committed to creating world-class healthcare
facilities, designed to compete on the global stage.
The premium service segment will continue to
Alisha Moopen, Aster DM Healthcare
Mariano Gonzales, Moorfields Eye Hospital
David Hadley, Mediclinic
#arabhealth
face challenges under the new regulations. The
coming years will drive customer segmentation and
consolidation on the provider side of the business.
This will put an additional pinch on those providers
who have ambitions of developing globally
competitive tertiary care facilities.
Premium healthcare providers like Moorfields
will also face the challenge of attracting world-class
doctors. “Another big challenge we face is attracting
experienced key staff that really want to pursue the
next chapter of their lives and their careers in the
UAE. Not only to attract them, but also to retain them.
It is getting more challenging to attract internationally
experienced specialist consultants and keep them,
unlike four or five years ago”, says Gonzales.
Alisha Moopen Director of Aster DM
Healthcare and Medcare Hospitals believes the
new regulations will be a growth driver for both
the bottom and premium segments of the market
as she says; “Although the main influx of numbers
to enter into the health system will be coming from
the bottom part of the pyramid who are largely
uncovered, I believe this will still have favourable
impact for the premium service segment to an
extent. Our premium brands such as Medcare
and Aster Plus still have a substantial portion of
the population that is uninsured and paying out of
pocket, and this segment will increase when this
part of the population is covered by insurance. It is
true that there is a cap on services, but the impact
is primarily on the lower segment.This is a new step
and a welcome initiative for the city as a whole, and
our sense is that the cap for services is mainly made
to protect the poorer classes of society.”
Moopen feels the premium segment will
eventually see it governed by new regulations as the
nation is keen to develop its tertiary care segment,
as well as participate in the growing healthcare
tourism market. “It is understood and appreciated
that getting the expert specialist doctors, particularly
from the West, is challenging and also expensive,
and therefore similar to the trend followed in Abu
Dhabi, we are likely to see different factors being
placed to measure the tariff level for the premium
segment, relative to the mid-income servicing
healthcare providers to enable organisations to
attract and retain the best talent from across the
globe”, says Moopen.
As the healthcare segment leaps into the
21st century, its players are forced to become
more competitive, more strategic and increasingly
customer-segmented. “We believe that mandatory
health insurance will encourage providers to
emphasise on cost containment. Dubai is also
stepping up its efforts on medical tourism in a
huge way. This will enable the premium segment
to capitalise in terms of focusing on these priceinsensitive revenue segments that presents a huge
opportunity for the GCC and MENA region. The
medical tourism market will further add volumes of
cases and a better case mix attractive to physicians
and surgeons to keep their skills intact, which is
typically a large concern at the moment as the case
numbers are low. We believe that the combination
of these factors, complemented by an economically
sound tariff structure will enhance the healthcare
system in Dubai and make it sustainable”, says
Moopen.
Over all, the healthcare market has moved
forward in leaps and bounds over the last decade,
however we are sure that we will see more
progress in the next five years than we have seen
in the past 20. The healthcare market is one of the
most interesting industries to watch in the UAE and
has attracted a flurry of private equity and foreign
direct investment since the financial crisis. This is
a trend we expect to continue and one that will
deliver significant changes for both the economical
and premium service offerings of the healthcare
market, potentially creating the bedrock for Dubai
to become the healthcare hub of the MENA region.
@arab_health
5
ARAB HEALTH daily dose
His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and Ruler of Dubai, visits Siemens Healthcare’s stand and is greeted by Mr Kay
Zwingenberger, Head of Healthcare MEA region at Siemens, at the opening day of Arab Health Exhibition and Congress 2015.
DUBAI HEALTHCARE CITY AND UAE MINISTRY
OF HEALTH COLLABORATE TO IMPROVE
CLINICAL SKILLS AND HEALTHCARE DELIVERY
D
ubai Healthcare City, the world’s
largest healthcare free zone,
has signed a memorandum of
understanding (MoU) with the UAE Ministry
of Health (MOH) towards clinical skills training
and medical education support.
Under the terms of the agreement,
the par ties will jointly develop healthcare
professionals’ capabilities and skills to
improve healthcare delivery in the country.
Towards medical education, DHCC
will collaborate with the MOH across
areas including clinical skills training and
development of scientific research through
its academic complex the Mohammed Bin
Rashid Academic Medical Center (MBRAMC). The complex is home to Al Maktoum
Medical Library, Khalaf Ahmad Al Habtoor
Medical Simulation Center and Dubai
College of Dental Medicine.
The two parties will also facilitate patient
referrals to deliver the required medical
expertise and services. The MoU builds on
DHCC’s continuous efforts to cement Dubai’s
position as a destination-of-choice for world
class healthcare and medical tourism. Marwan
Abedin, CEO, Dubai Healthcare City and His
Excellency Awadh Seghayer Al Ketbi, Assistant
Undersecretary for Support Services, Ministry
of Health signed the agreement.
“The cooperation between DHCC
and MOH achieves our common vision of
promoting and developing the healthcare
sector in Dubai and the UAE. The agreement
will expedite the exchange of expertise for the
benefit of the UAE community”, said Abedin.“All
educational and training resources provided by
the Mohammed Bin Rashid Academic Medical
Center will be made available to deliver on the
goals of the agreement.”
HE Al Ketbi commented: “We are pleased
to sign this agreement with DHCC, and we
look forward to working closely with all
stakeholders involved in the development
of local healthcare professionals. This is in
line with the vision of His Highness Sheikh
Mohammed Bin Rashid Al Maktoum, Vice
President and Prime Minister of the UAE and
Ruler of Dubai, who categorised healthcare
and education as key sectors for the
sustainable growth of our nation.”
ROYAL BROMPTON & HAREFIELD HOSPITALS
PERFORM LIVE ‘ARTIFICIAL HEART’ REPLACEMENT
SURGERY DEMONSTRATION AT ARAB HEALTH
A surgical simulation of ground-breaking transplant
procedure delivered by international expert
R
oyal Brompton & Harefield Hospitals
(RB&HH), the UK’s largest specialist
hear t and lung centre, showcased its
pioneering ar tificial hear t replacement surgery
at the Arab Health conference yesterday. The
highly complex procedure was explained and
demonstrated by Dr Andre Simon, one of
Europe’s top hear t surgeons.
The new generation ventricular assist device
(VAD) procedure, also known as ‘an artificial heart’,
involves the insertion of a mechanical pump in the
left or right heart chamber in order to support
heart function in people with cardiovascular
disease (CVD) or have suffered heart failure. The
device takes blood from a lower chamber of the
heart and helps pump it to the body, just as a
healthy heart would.
RB&HH currently operates the largest VAD
centre in the UK, and many of its patients are
demonstrating the highest rate of myocardial
recovery in the world.
CVD is an increasingly serious issue in the Middle
6
facebook.com/arabhealth
East. According to the World Health Organization,
diseases of the heart and blood vessels are
responsible for as many as 45% of all deaths in
the region. “CVD is the biggest killer in the Middle
East and patients from the region are looking for
the best healthcare available”, commented Andre
Simon, Director of Heart and Lung Transplantation
and VAD, RB&HH. “This revolutionary procedure
has already provided a much-needed solution for
thousands of patients around the world and we
look forward to bringing it to the Middle East at
this year’s Arab Health conference.
“As well as delivering a pioneering showcase,
the live demonstration provided a unique insight
into this complex treatment.Thousands of patients
around the world are choosing it as an alternative
to a heart transplant, whilst others receive VADs
while they wait for a transplant. I am proud to say
that today RB&HH has the largest population of
patients ‘bridged’ to transplant with an artificial
heart in the UK.”
The demonstrations were held yesterday
morning, attended by a number of high profile
international medical professionals including Lord
Ajay Kumar Kakkar, an advisor to the UAE Ministry
of Health and an internationally renowned surgeon.
RB&HH, which comprises two specialist
hospitals; Royal Brompton and Harefield is
renowned for its expertise, standards of care
and research breakthroughs. It works closely
with hospitals, specialist medical centres and
other health providers across the Middle East
to promote clinical excellence and exchange
of international expertise. As one of the largest
specialist heart and lung centres in Europe,
RB&HH treat patients from across the world.
Care at RB&HH is provided in comfortable
surroundings in private wings within the main
hospital buildings, 24 hours a day, seven days a
week. The hospital’s dedicated concierge services
and International Liaison Officers provide practical
support to overseas patients and their families,
paying particular attention to their cultural,
religious and language needs.
TUESDAY 27 January 2015
NEW RESEARCH SHOWS PROMISE FOR treating PAEDIATRIC BRAIN TUMOURs
B
rain tumours are the leading cause of
cancer-related deaths in children under
age 10 and the second leading cause
of cancer deaths in people under 20. Brain
cancer is one of the most difficult cancers to
treat, but researchers at Dana Farber/Boston
Children’s Cancer and Blood Disorders Center
are working towards increasing survival rates
dramatically in the years ahead.
Although survival rates for children with
some types of brain tumours have risen over the
past 30 years, current research aims to increase
those rates dramatically. Scientists are focusing
on the basic genetic and genomic errors that
spawn tumours, and at the elements of the
tumour ‘microenvironment’, the web of tissues
and substances that surround tumours, to better
understand the origins of brain cancers and how
they may be combated in the future.
Some recent advances include:
 Researchers at Dana-Farber/Boston Children’s
Cancer and Blood Disorders Center and other
institutions have found that medulloblastomas
(fast-growing tumours that arise primarily in
the cerebellum) can be divided into four main
subtypes based on the genetic errors in their
cells. The researchers have helped develop a
diagnostic test for these subtypes and are leading
clinical trials of drugs that target several of them

To
improve
the
ability
of
some chemotherapy drugs to reach brain
tumours, investigators have coated some of
these drugs with tiny layers of fat, which may help
them cross the blood-brain barrier, the mesh of
capillaries that protects the brain from foreign
substances. Another approach under study is to
attach chemotherapy agents to molecules that
normally cross the blood-brain barrier
 Researchers have recently generated a firstof-its kind mouse model for paediatric low-grade
gliomas, cancers that arise in cells that support
and surround nerve cells in the brain. The new
model, in which tumour cells carry the same
genetic alteration found in human tumours, will
enable scientists to better predict how effective
new drugs will be in patients

Researchers
at
Dana-Farber/Boston
Children’s and McGill University have found
several molecular alterations that drive a rare,
fatal paediatric brain tumour known as highgrade astrocytoma. Such tumours are extremely
difficult to treat with radiation and surgery. At
least two of the newly found gene alterations,
or mutations, found in one form of high-grade
astrocytoma might be susceptible to blocking by
existing drugs
 Another group of scientists at Dana-Farber/
Boston Children’s identified a mutated gene that
causes tenacious brain tumours known as
papillary craniopharyngiomas. Though benign,
such tumours can have severe lifelong effects. In
children, the tumours often carry a mutation in
the gene CTNNB1, the researchers found, which
spurs an onslaught of growth in tumour cells.
Although no CTNNB1-blocking drugs have yet
reached the clinic, several groups are working on
developing them. The discovered mutated gene
(BRAF) is responsible for craniopharyngiomas in
adults. The finding was especially encouraging
because drugs exist that inhibit this gene’s effects
 Scientists have long known that cancer cells
with a high oxygen-content are particularly
vulnerable to radiation therapy. Investigators
are exploring whether drugs that increase the
oxygen supply in tumours can enhance the
effectiveness of radiation therapy in paediatric
brain cancer patients
 Dana-Farber/Boston Children’s researchers
have found that paediatric low-grade gliomas
often harbour an unusual genetic mutation that
may help to classify, diagnose, and guide the
treatment of the tumours. An analysis of several
dozen tumour-specimens revealed that a gene
called MYBL1was rearranged or missing a part
of its genetic message in nearly 30% of them.
LEARN MORE
Find out more about Dana-Farber/
Boston Children’s services at www.
danafarberbostonchildrens.org/learn-more.
Four-year old Khalid Al Ansari and his parents
embarked on a global air ambulance journey from
Dubai to Boston to access the best treatment for
Khalid’s brain tumour. Image © Dana Farber/
Boston Children’s
NEW ACTUATOR FROM LINAK INCREASES
LIFE EXPECTANCY OF HOSPITAL BEDS
LINAK reveals their new actuator LA40 at Arab Health
T
he new actuator has been constructed
with special focus on hospital beds, which
is why the new LA40 is crafted for a longer
durability and the ability to lift up to 8,000N.
With hospital beds life expectancy reaching 20
years and the world’s population getting heavier
and heavier, the pressure on actuators in hospital
beds is increasing. The leading expert in electric
linear actuator systems, LINAK, has constructed a
new actuator with the capabilities needed to meet
the increasing demands of hospitals.
“We developed the new LA40 actuator with
one thing in mind; to put all our knowledge about
actuators into one product that could tolerate
maximum weight while having a long lifespan”,
Anders Hamborg-Petersen, Export Manager at
LINAK explains.
HYGIENIC AND CAREFULLY
TESTED
The LA40 is different from other actuators
because it has been thoroughly tested to sustain
overload and encompass strict cleaning restrictions
in hospitals.
Anders Hamborg-Petersen explains, “Today
there is an extremely high focus on hygiene in
hospitals, which is why the LA40 has a cleaning
friendly design and IPX6 washable protection.”
higher, the weight is lower and the technology is
environmentally friendly.
“We look forward to presenting our new
battery and actuator at Arab Health. Anders
Hamborg-Petersen sums up; “This will be our fifth
visit to the show, and we are always very pleased
to take part in Arab Health.”
Image © LINAK
NEW AND GREENER
BATTERIES
At Arab Health, LINAK will also present a
new battery type for patient lifts. LINAK’s new
lithium Ion technology battery is a more green
solution that lasts longer. The battery capacity is
#arabhealth
@arab_health
7
ARAB HEALTH daily dose
GE’S ADVANCED TECHNOLOGIES
AND SOLUTIONS SUPPORTING
GOVERNMENT DEVELOPMENT GOALS
FOR BETTER ARAB HEALTH
A
t Arab Health, GE Healthcare is highlighting
its advanced suite of technologies, systemwide solutions and commitment to
localised partnerships to drive transformational
change in the region’s healthcare sector, building
on more than four decades of experience in the
region. With a strong local footprint, some 80,000
GE technologies are deployed in hospitals and
clinics across the Middle East region.
Today, as the region places the highest emphasis
on promoting social development through
sustained investments in advanced healthcare
infrastructure, GE’s technologies serve as a strong
complement to achieving the development vision
of the governments.
Maher Abouzeid, President & CEO of GE
Healthcare for Turkey and the Middle East, said:
“Across the region, there is great emphasis today
on providing an earlier model of healthcare that
focuses on preventative measures rather than
treatment, leveraging diagnostic technologies to
address the growing incidence of lifestyle diseases.
This is particularly important to address the growing
healthcare bills and counter the costs associated
with the rise of non-communicable disease, for
instance heart disease, which for example is the
biggest killer in the UAE.”
He said that GE’s approach is an ideal fit to the
region’s strategic growth goals, as underlined by
the Dubai Plan 2021, announced recently, which
places ‘healthy individuals’ as a fundamental priority.
Other countries across the Gulf and the Levant,
representing a wide-range of healthcare systems, are
equally investing in better health for the prosperity
of their populations.
Mazen Dalati, President & CEO for GE
Healthcare in Saudi Arabia echoed this view. “In line
with its health sector development plans, we see
the Kingdom’s leading public and private healthcare
partners, including the Ministry of Health, driving
ongoing efforts to strengthen the Kingdom’s
healthcare services at all levels of healthcare to
meet the evolving needs of all Saudis.”
The diverse array of advanced technologies
showcased by GE Healthcare at Arab Health
cover all specialisations including oncology,
cardiology, neurology and radiology. Several of these
technologies are now available at leading healthcare
institutions, both in the public and private sector
across the Middle East.
One of the path-breaking innovations is GE’s
Revolution CT, a state-of-the-art technology
that uses high-resolution and motion correcting
technology similar to the image stabilisation features
in personal cameras. The blend of speed and clarity
is important because it allows doctors to retrieve
sharper images with higher resolution at lower
radiation doses.
Cardiologists can use the Revolution to image
patients with high heart rates, oncologists can use
its low-dose settings to study liver, kidneys, pancreas
and other organs, and neurologists can quickly assess
brains of stroke patients. In the most advanced CT
technology, GE’s Revolution EVO enables clinicians
to perform more exams in less time, while providing
high quality images and less dose to the patient.
GE’s Voluson E10 is a new 4D high-performance
ultrasound system, featuring the world’s first curved
matrix electronic 4D probe designed specifically for
obstetric and gynaecological applications. Aside from
parent-pleasing spectacular detailed colour images
of an unborn child, Voluson E10 allows clinicians to
monitor a child’s brain and heart development from
as early as the first trimester.
The SIGNA** Pioneer with MAGiC1, an MR
system, is another cutting-edge technology designed
to enable clinicians to scan one more patient, every
hour, every day. Developed in collaboration with
SyntheticMR AB, MAGiC is engineered to help
clinicians capture six image contrasts in a single
scan in one-third of the time; an industry first in
workflow efficiency. Fewer, faster scans producing
quality diagnostic images, indeed, is good news for
patients and clinicians alike.
The CARESCAPE R860, an intuitive Critical
Care ventilator that uses advanced lung protection
tools and an innovative user interface, is another
technology that helps improve patient care, while
the Discovery* IGS 740, a mobile angiography
system, is specifically designed to improve clinical
efficiency in the operating room, whilst also offering
high quality imaging. Its wide bore C-Arm and
dedicated arm-imaging positions help clinicians to
easily image the anatomy of interest, and offer full
patient access from the left or right.
The Platinum Sponsor of Arab Health, GE
Healthcare is also extending its support to the show
conferences on Big Data, Leaders in Healthcare,
Biomedical Engineering and Radiology.
*Trademark of the General Electric Company
**510(k) pending at FDA. Not available for sale in
the United States. Not yet CE marked. Not available
for sale in all regions
SIGNA Pioneer and MAGiC are 510(k) pending
at the FDA and not available for sale. Not CE Marked.
Image © GE Healthcare.
Image © GE Healthcare
8
facebook.com/arabhealth
ERAS PROGRAMME,
INCLUDING FLUID THERAPY
TAILORED TO MASIMO’S PVI®,
SHOWS REDUCED LENGTH OF
STAY AND COST SAVINGS
Findings Presented at American Society
of Anesthesiologists Annual Meeting
R
esults of a retrospective study of an
Enhanced Recovery After Surgery
(ERAS) programme in colorectal
surgery patients, which included Masimo’s
PVI® monitoring, were presented at the
American Society of Anesthesiologists
(ASA) Annual Meeting in New Orleans.
The ERAS programme, which included fluid
therapy tailored to PVI, resulted in reduced
length of hospital stay, significantly reduced
hospital costs, lower fluid administration,
lower morphine administration, and earlier
return of bowl function.
In the retrospective study of the ERAS
programme implemented at the University of
Virginia, Dr Robert H. Thiele and colleagues
compared the results of 108 patients
managed with the ERAS programme to 98
consecutive patients before the programme
was implemented. The programme included
goal-directed therapy with PVI, ingestion of a
carbohydrate drink two hours prior to surgery,
pre-operative multimodal analgesic regimen,
intraoperative low-dose spinal morphine,
limiting intraoperative opiates, intraoperative
infusions of ketamine and lidocaine (continued
Image © Masimo
48 hours post-operatively), early mobilisation,
and oral intake post-operatively.
Patients whose care was guided by the
ERAS programme with PVI had less fluid
administered (973 ml vs. 3,000 ml, p<0.001),
lower morphine equivalents (0.1 vs. 20,
p<0.001), earlier return of bowel function
(p<0.03), lower pain score (2.33 vs. 4.85,
p<0.001), fewer days of hospitalisation (3 vs.
5 days, P<0.001), and lower hospital costs
(US$18,017 vs. US$15,150, P<0.01).
The investigators concluded: “While this
programme includes several measures, most
significantly, patients received markedly less
fluid and opiates in the operating room. Our
programme is novel in the use of PVI to guide
therapy. This work highlights the importance
of selection of anaesthesia technique in
determining outcomes for patients. Our
ongoing work is in applying the lessons
learned from this programme to patients
undergoing other types of surgery.”
REFERENCES
References available on request (magazine@
informa.com)
TUESDAY 27 January 2015
F1 INSPIRED WHEELCHAIR TO MAKE ITS FIRST
INTERNATIONAL APPEARANCE AT ARAB HEALTH 2015
C
arbon Black, designed and developed
by Andrew Slorance, is not like other
wheelchairs. It is highly engineered, highly
stylised and built entirely from carbon fibre by
Formula 1 engineers in the UK. Carbon Black
System, the company behind the Carbon Black
wheelchair, will be attending Arab Health 2015;
the first time the wheelchair will be available for
demonstrations and viewing outside of the UK.
After suffering a spinal injury at the age of 14,
Andrew decided that he would one day re-design
the wheelchair. After years of waiting for a revolution
in wheelchair design that never happened, Andrew
took matters into his own hands and set about
designing and manufacturing a wheelchair that
would be as much about design as practicality.
“I felt that wheelchairs were horrible medical
devices, and couldn’t understand why companies
didn’t advance their wheelchairs in the same way
bike companies did with their products. By the time
I was sixteen I had decided that one day I would
re-invent the wheelchair.”
After a 20-year career in TV production, Andrew
resigned and started working on his dream. Six years
later Carbon Black was born; sleek, sophisticated
and shortlisted for Design of the Year in 2012.
Carbon Black is no ordinary wheelchair; it is highly
stylised and aimed at discerning customers who
desire and demand luxury in all aspects of their life.
It is designed with the active, independent user in
mind, someone to who style matters as much as
practicality. A minimalist style chair allows the users
own unique style and personality shine though, and
for the user to feel confident and empowered.
Made by F1 engineers from F1 spec carbon fibre,
the aesthetic form of Carbon Black is the result of
a chair built to make life as a wheelchair user easier.
Carbon fibre is the perfect material to work with, as
the chair is designed to be minimal and lightweight
as well as being robust enough for everyday use.
The aesthetics of carbon fibre, clean and stylish, also
fitted this remit.
After a successful launch in the UK, the company
now has it sites set firmly on international markets.
Andrew says: “In five years I’d like Carbon Black to
be recognised as the best wheelchair in the world
and available in any country around the globe.”
LEARN MORE
Carbon Black System will be attending Arab Health
to make contact with potential distributors to
enable international sales and distribution of Carbon
Black. Andrew will be on the Scottish Development
International stand (Z4D10) with Carbon Black at
Arab Health and is available for meeting potential
distributors throughout the exhibition.
Image © Carbon Black System
ENTERAL CONSUMABLES
MARKET LEADER PREPARED
FOR NEW ISO AT ARAB HEALTH
a unique patient proning device called
Intoprone, which is used in theatres. The easyto-use one-piece device eliminates the need
to ‘catch’ the patient and also reduces the risk
of staff injur y. The Intoprone also provides
complete control of the patient during turning
improving patient safety. At Arab Health,
GBUK will endeavour to find distributors
in new markets, and raise brand awareness
internationally, par ticularly of pressure area
care. The company also aims to speak with
hospitals, ministers of health and any clinical
specialists with an interest in tissue viability.
GBUK Ltd are located at stand Z1G57 in
the Za’beel Hall, and will exhibit its products
including enteral syringes, nasogastric tubes
and dilators – all available with the new
connector.
A robotic telepresence device
which provides seamless internet
connectivity from any operating
theater.
It will transform the manner by which clinicians communicate and
share vital medical information. It is now possible to be in more
places at once and extend your presence in the theater.
VisitOR1® Telesurgical Robot
Connectivity Made Easy
OR1 48 04/2014/A-LB
G
BUK Ltd, one of the UK’s market
leaders in enteral consumables, will
be showcasing its range of products
that have been prepared for the new Enteral
ISO directive at Arab Health 2015. In an effor t
to improve patient safety, new international
design standards for medical device tubing
connectors will be released from early
2015 as par t of a phased global initiative.
The International Standard (ISO 803693) will cover all enteral connectors and the
new global enteral feeding device connector
designed (named ENFit).
GBUK has already developed its range of
products to meet the requirements of the
new ISO standard for connectors and ensure
its customers are prepared well in advance
of the change. Marcus Ineson, GBUK Ltd
Group Marketing Director, said: “GBUK is well
advanced in its preparation for the new ISO
directive in the enteral market, which means
our customers and their end-users will also
be well prepared, and ultimately meaning
enhanced patient safety.
“GBUK has played a key role on an
international planning committee to help
raise awareness of the new directive, working
with healthcare professionals and patient
organisations from across the globe. We’re
now looking to bring that exper tise to
customers, clinicians and patients across the
Middle East.”
“At Arab Health we are looking to meet
new distributors and expand our range in to
a growing market which demands the highest
quality from its medical products.”
The company will also be showcasing
KARL STORZ GmbH & Co. KG, Mittelstraße 8, 78532 Tuttlingen/Germany Telephone: +49 (0)7461 708-0, Fax: + 49 (0)7461 708-105, E-Mail: [email protected]
KARL STORZ Endoskope – East Mediterranean and Gulf S.A.L, Block M, 3rd Floor, Beirut Souks, Weygand Street, 2012 3301 Beirut/Lebanon,
Phone: +961 (1) 999390, Fax: +961 (1) 999391, E-mail: [email protected]
www.karlstorz.com
#arabhealth
@arab_health
9
ARAB HEALTH daily dose
DRIVE MEDICAL LAUNCH
EXPEDITION PLUS WHEELCHAIR
D
rive Medical Ltd is exhibiting its range
of wheelchairs, bathing aids and
paediatric equipment at Arab Health
2015, including the brand new Expedition Plus
wheelchair.
The company will be showcasing the
Expedition Plus Wheelchair as part of its travel
range at stand Z1F54 in the Za’abeel Hall. The
Expedition Plus offers Drive’s most featurerich travel chair providing excellent practicality
and comfort. It has an attractive blue finish
with a lightweight aluminium frame for easy
manoeuvrability.
The paediatric Trekker Gait Trainer, which
encourages early cognitive and learning
development and also cardiopulmonary
strengthening and conditioning, will also be
on the Drive stand. The trainer teaches the
individual to take steps independently.
Alan Sullivan, Sales and Marketing Manager
at Drive Medical said: “We are pleased to be
exhibiting at Arab Health for the seventh time.
All our products have undergone extensive
research and development to ensure we offer
quality products that offer excellent value. “We
look forward to meeting with existing customers,
contacts we have met at previous Arab Health
shows and potential new customers.”
At Arab Heath, Drive hope to speak to
hospital- and private nursing home supply
companies, mobility retailers
and
distributors
based
throughout the Middle East.
They are particularly interested
in opportunities in Saudi Arabia
as well as in Iran.
The Trekker Gait Trainer.
Image © Drive Medical
ROCHE DIAGNOSTICS MIDDLE EAST SHOWCASES
CUSTOMER TRAINING CENTRE AT ARAB HEALTH 2015 WITH
PREVIEW SESSIONS OF THE ‘CLASSROOM OF THE FUTURE’
R
oche Diagnostics Middle East has long
displayed its commitment to developing
expertise and knowledge in the region
with highly qualified personnel and high standards
of quality. Taking its services one step closer to
the healthcare professionals, Roche Diagnostics
Middle East recently announced the launch of its
Customer Training platform; the RDME Academy.
With the launch of this platform, real-time
laboratory and learning tools are now accessible
to industry experts at the click of a mouse through
the RDME Academy website for both online and
in-class training. Industry experts will be able to
experience the RDME Academy Classroom of the
Future delivered directly by Roche experts during
the 40th Arab Health Exhibition.
Previously, tailored training sessions were
available to healthcare professionals through
Roche Diagnostics Middle East’s training centres
throughout the region with approximately 1,400
participants; however, the new RDME Academy
website will now afford users with a comprehensive
one-stop learning platform that gives them access
to the entire training catalogue all at once, anytime
and anywhere.
As part of its dedication to meet medical
needs in the region, Roche Diagnostics Middle
East developed the training centre as a response
to the industry’s demand for an updated source
of diagnostic information. The user-friendly RDME
Academy interface helps deliver tangible benefits
to both patients and clinicians with the widerange of knowledge and information. Using their
personalised user dashboard, customers will be
able to select the courses they would like to attend.
In-class sessions are available throughout several
locations in the Middle East, including the UAE,
Egypt, and Saudi Arabia, and scheduled regional
trainings are constantly updated. Offering even
more flexibility, the platform also delivers online
training with videos from expert specialists and
10
detailed presentations. Users can begin their online
training at any time and continue later, according to
their schedules. With more than 24 different topics,
the training catalogue allows clinicians to stay up-todate with developments in the in vitro diagnostics
industry, covering areas such as laboratory topics
in quality, safety, and accreditation; medical value;
product knowledge topics, and advanced system
operator trainings.
Continuous training is a necessity for lab
personnel, particularly during the introduction of
new systems and applications. The customised
Image © Roche Diagnostics
facebook.com/arabhealth
courses available in Roche’s Customer Training
Academy not only ensure that new equipment is
properly operated, but also, for example, that the
medical value of tests and assays is fully understood.
The advanced system operator trainings are
especially useful, as end users in the past had to rely
on post-installation training and support done by
Roche’s application specialists. Now, in addition to
post-installation training, Roche Diagnostics Middle
East aims for better operators in laboratories, which
will lead to better optimisation of instruments,
better diagnoses, and ultimately better expertise
and patient care in the region.
Developed in just under a year, RDME
Academy has set a benchmark that healthcare
professionals can rely on to deliver full training
experiences from start to finish. The extensive
and broad option of training available gives
clinicians’ direct access to Roche Diagnostics’
expertise and the newest industry developments.
To experience the RDME Academy Classroom
of the Future, visit the Fujeirah Lounge area of
Roche Diagnostics Middle East during the show
and witness the future of expertise exchange.
TUESDAY 27 January 2015
ESTABLISHED FACULTY OF HEALTH STUDIES TO
LAUNCH NEW INTERNATIONAL PROGRAMMES
OF STUDY AT ARAB HEALTH 2015
T
he Faculty of Health Studies at the
University of Bradford will showcase
their already established and brand new
academic programmes of study, including MSc
and BSc Nursing Studies (International) and MSc
International Healthcare Management, at Arab
Health 2015.
The Faculty of Health Studies, who will be
exhibiting on stand Z1E72 in the Za’abeel Hall, are
attending Arab Health to identify the education
and development needs of healthcare professionals
in relation to their leadership and professional
development.
The University of Bradford in Dubai are
established providers of quality academic
programmes in healthcare leadership/management
and are introducing new provision for professional
nurses. Their study programmes are approved by
the Knowledge and Human Development Authority
in Dubai and are quality assured by the UK Higher
Education Quality Assurance Agency.
Ruth Girdham from the Faculty of Health Studies
at the University of Bradford, said: “We are proud to
already be established in Dubai. The first Masters
graduates recently celebrated their graduation at
the Dubai Health Authority in November 2014 and
we are delighted to be expanding our provision to
include nursing specific programmes.
“We pride ourselves on offering excellent
student support and being a professional, research
active, academic faculty.” At Arab Health the Faculty
of Health Studies at the University of Bradford
would like to meet clinicians, managers and leaders
from the Middle East.
Image © University of Bradford, Dubai
SOUNDEAR LAUNCHES NEW
SOUND VISUALISATION SERIES
N
Sullivan in 2014. The international agency
chose SoundEar because its products for
the health sector are characterised by an
otherwise unseen high quality. “Our new
SoundEar III series are the most precise
devices in the market and the products can
for instance be connected through cable, WiFi or gsm”, Rasmussen says.
SoundEar III products will be available in
two different varieties; one with display and
one without, depending on whether the
individual device should be able to provide
alerts or not.
Enjoy access to
your exclusive
Image © SoundEar
Za’abeel 4
Novotel Hotel
Sheikh
8
g
Rashid
rkin
3
Sheikh
2
5
2
rse
1
6
Pa
7
Pavillion
Za’abeel 3
id
Pa
Za’abeel 2
cou
Za’abeel 1
Maktoum
Con
oise levels above 50 dB(A) have
been scientifically proved to
negatively affect patient recovery
and increase complications in surgery.
Therefore, SoundEar has created a series of
products for visualising noise in hospitals. The
new series is called SoundEar III and it will be
launched at Arab Health.
Noise is an increasing challenge of the
indoor climate in hospitals in line with
temperature fluctuations and air humidity.
Too much noise will affect staff and patients.
However, it is impossible to resolve noise
issues in hospitals without first knowing
where noise is a problem and then being
able to provide an instant alert. Because of
that, SoundEar’s newest products are made
especially for visualising areas of noise and
alerting the specific area in hospitals.
“SoundEar III is a series of products that
are made for hospitals with all the special
needs and issues they have, including medical
approval in accordance with IEC 60601-1
(medical electrical equipment)”, Lars Boldt
Rasmussen, CEO of SoundEar explains.
SoundEar III is mounted onto a wall,
showing the noise level in an easy-tounderstand manner, and it omits a warning
whenever the noise level gets too high.
Are you a dealer
or distributor?
Ibis Hotel
4
Al Multaqua Registration
Ballroom
Concourse 1
Trade Centre
Arena Plaza
(Outside Area)
Arena
Sheikh
Saeed 1
Sheikh
Sheikh
Saeed 2 Saeed 3
Plaza
Hall
COMPANY OF THE YEAR
SoundEar’s products are market leading in
the hearing conservation industry, which is
one of the reasons why the Danish company
was announced ‘Company of the Year in the
Hearing Conservation Industry’ by Frost &
Go to Za’abeel Hall 4
Stand Z4N60
#arabhealth
@arab_health
11
ARAB HEALTH daily dose
/ArabHealthExhibition
EMIRATI WOMAN LEADERSHIP FAST-TRACKING
THE LANDSCAPE OF VPS HEALTHCARE GROWTH
IN DUBAI AND NORTHERN EMIRATES
Subscribe to our
YouTube Channel
to keep up to date
with all our videos
and products
12
T
he integrated healthcare provider has hired
female Emirati Dr Ibtesam Al Bastaki to head
expansion and opening of second multispeciality hospital Medeor 24x7 in Dubai shortly.
In its efforts to diversify and Emiratise its
innovative leadership team, VPS Healthcare, an
integrated healthcare provider with a network of
hospitals and medical centres, has announced the
addition of Dr Ibtesam Al Bastaki as Director for
Dubai and the Northern Emirates.
Dr Shamsheer Vayalil, Managing Director, VPS
Healthcare, has expressed strong dedication to the
continued growth of operations both in the UAE and
abroad by on-boarding the best and most experienced
professionals from a diverse array of backgrounds.
“Building a successful healthcare organisation
requires diverse talent, medical expertise, stateof-the-art technology and, above all, coordination
between different organisations”, explained Dr
Shamsheer Vayalil, “only by maximising these
attributes we can establish a truly successful
healthcare delivery system. Dr Ibtesam will now be
a vital part of this growing architecture.”
As the new Director of Dubai and the Northern
Emirates, Dr Ibtesam Al Bastaki will be responsible
for the development and improvement of healthcare
strategy and performance for VPS Healthcare’s in
these areas. She brings with her more than 15 years
of distinguished experience in healthcare.
In the short time since she joined VPS Healthcare,
Dr Ibtesam has prepared a detailed roadmap for
successful growth in Dubai and the Northern
Emirates and is all set to open the new facility in
Dubai under the brand name of Medeor 24x7.
Medeor 24x7 Hospital will be a premium multispeciality hospital offering an exceptional, communitybased healthcare delivery system with a full continuum
of high quality and efficient medical services. The
hospital comprises of around 100 beds across all major
specialities with an expert team of doctors on board
to create Centres of Excellence, such as Mother &
Child Care, Urology, Gastroenterology and laparoscopic
surgery. On offer is also a state-of-art laboratory and
diagnostic imaging facilities, such as the 1.5 tesla MRI,
high-end 160-slice CT scan and dual detector x-rays.
The United Arab Emirates is actively expanding
Medeor 24x7 Hospital Dubai. Image © VPS Healthcare
its national healthcare system to meet the growing
needs of both Emiratis and expatriate residents, with
these developmental requirements now flowing
north, beyond Abu Dhabi and Dubai. This is partly
the result of favourable government policies, as well
as a response to rising costs in the southern Emirates,
where real estate prices are soaring.The private sector
is working to meet the increasing demand for highquality, accessible healthcare. Dr Ibtesam’s hiring comes
just a week after VPS Healthcare announced the hiring
of its new Chief Executive Officer, Dr Ali Obaid Al-Ali,
with the objective of strengthening its leadership by
bringing talented and distinguished Emiratis on board.
“As the nation strives to realise its healthcare
goals under the direction of the Ministry of Health,
we strongly believe that the evolution of healthcare
services will be of top priority in the northern
Emirates, having a positive effect on the entire
country”. Dr Vayalil further said that Dubai’s status
as an ascendant global city offers ideal opportunities
to draw medical tourism by creating world-class
facilities that will attract patients from neighbouring
countries in the region, as well as minimising
outbound medical tourism. This will lead to an
accelerated economic development for the UAE.
VPS Healthcare opened its first hospital, the
Burjeel Hospital for Advanced Surgery on Sheikh
Zayed Road in Dubai last year, and in a short time, it
has become one of the finest medical facilities in the
UAE, providing top-quality, state-of-the-art services
in joint surgery, paediatric orthopaedics, hand
surgery, sports orthopaedics, and spine surgery
amongst others.
Dr Ibtesam’s role is critical to VPS Healthcare
due to her intimate understanding of the needs of
Dubai and the northern Emirates, coupled with her
strong background in health strategy and regulation.
Prior to joining VPS Healthcare, Dr Ibtesam
served as the Director of Health Operations
and Business Development at the Dubai Health
Authority (DHA) where she was responsible for
the development and improvement of overall
healthcare performance, amongst other tasks.
She was also a member of the Governance
Council of the International Hospital Federation
and a scientific chair for the International Family
Medicine organisation. Dr Ibtesam also served as
Head of Health Strategy & Performance at the Prime
Minister’s Office (PMO) where she was involved
in federal KPI and healthcare strategy. Dr Ibtesam
has been an active participant in her community,
promoting various health awareness programmes.
ARAB HEALTH SEES REGIONAL LAUNCH OF
SMALLEST ALL-IN-ONE VITAL SIGNS SOLUTION
T
he world’s smallest all-in-one vital
signs solution will be the highlight of
the Rigel Medical display of medical
device analysers, electrical safety testers and
simulators at this year’s Arab Health (Z1B12).
Rigel’s hand-held vital signs simulator
UNISIM, capable of undertaking six
synchronised vital signs parameter tests
simultaneously, has been linked with the
new PULS-R SpO2 simulation finger to
provide improved vital signs simulation and
measurement.
UNISIM can check NIBP, SpO2, ECG,
temperature, IBP and respiration functionality
in a single test, while the compact Rigel
PULS-R universal SpO2 simulation finger
can produce accurate SpO2 simulations in
1% resolution from as low as 30% using
the pre-programmed manufacturer specific
R-curves. It can also be configured to meet
customer specific R-curves via a simple-to-use
configuration tool.
Also showing will be the MULTI-FLO
infusion pump analyser, which leads the way
in high and low flow, occlusion, back pressure
and bolus measurement and meets the
requirements of IEC 60601-2-24.
Featuring variants of one, two and four
facebook.com/arabhealth
independent channels, each MULTI-FLO
channel can be tested simultaneously across
a range of 100μL to 1,500 mL per hour with
results stored in the instrument’s large internal
memory. With a sampling rate of 1Hz, the
analyser accurately details changes in flow and
pressure rates, providing a real-time picture of
the quality of infusion.
Associate Director John Backes said: “Arab
Health is a key show and this year we look
forward to using it as the perfect platform to
launch our world leading, all-in-one vital signs
simulator solution to the important Middle
East market.”
The UNI-THERM, which provides fast
testing of all leading electrosurgical devices,
providing accurate results as it quickly and
automatically guides the user through test
procedures, and the UNI-PULSE defibrillator
analyser will complete Rigel Medical’s display.
Image: UNISIM and PULS-R, the world’s
smallest all-in-one vital signs solution, will lead
the way for Rigel Medical at this year’s Arab
Health. Image © Rigel Medical.
TUESDAY 27 January 2015
ANNOUNCING HARVARD MEDICAL SCHOOL CENTER FOR GLOBAL HEALTH DELIVERY—DUBAI
Centre to build a vital regional hub for innovative research and education in Dubai
H
arvard Medical School and Dubai
Healthcare City Authority have
signed an agreement to cooperate in
establishing the Harvard Medical School Center
for Global Health Delivery in Dubai.
The centre’s mission will be to increase local
and regional health delivery research capacity
in the UAE. The new health research and
training centre will address some of the most
pressing health challenges in Dubai and the
region, expanding Dubai’s role as a global hub
for scientific and policy discussions related to
healthcare delivery. Funding for the centre will
be provided by a four-year grant from the Dubai
Harvard Foundation for Medical Research.
The new centre, directed by Salmaan
Keshavjee, Associate Professor of Global Health
and Social Medicine at Harvard Medical School
and director of the Programme in Infectious
Disease and Social Change in the Depar tment
of Global Health and Social Medicine, will be
based at the Mohammed Bin Rashid Academic
Medical Center in Dubai Healthcare City.
“The work of the centre will suppor t our
long-term commitment to improving the health
of all communities within Dubai and enhance our
oppor tunities to lead the region in advancing
health care research and delivery”, said Her
Excellency Raja Al Gurg, Vice-Chairperson of
Dubai Healthcare City Authority. “Establishing
the centre will foster excellence amongst
students, scientists and healthcare providers for
the ultimate benefit of Dubai and those beyond
our region.”
“We are privileged to par tner with our
colleagues in Dubai to generate best practices
in global health delivery and transform these
practices into improved health outcomes in
Dubai, the region and the world”, said Jeffrey S.
Flier, Dean of the Faculty of Medicine of Harvard
University. “It is our hope that the new centre
AH2015 VUE AD 18x26.7cm
BIG D ATA = BIG OPPORT UN IT Y.
will catalyse health delivery research and spur
innovative solutions that address significant
health delivery obstacles.”
The new centre will allow Harvard Medical
School, working with researchers and care
providers from the health authorities in the
UAE, to stimulate research and education
focused on improving the delivery of highquality healthcare. Using innovative and
multidisciplinary approaches, the centre will
study ways to improve outcomes for patients
undergoing surgery and for patients receiving
care for diabetes and obesity, infectious diseases
such as tuberculosis and hepatitis C, and mental
health disorders.
The activities of the centre aim to contribute
to improved healthcare delivery; to strengthen
the research environment in Dubai, the UAE
and the region; and to contribute to regional
social and economic development. The centre
will also expand training capabilities for regional
faculty and students. The centre will not provide
patient care.
“The scope of this project is broad, and its
impact promises to be great. It will provide
rigorous training for tomorrow’s scholars and
practitioners. It will also conduct health delivery
research, whose findings will influence global
health practice as well as policy”, said Alan
Garber, Provost of Harvard University and the
Mallinckrodt Professor of Health Care Policy at
Harvard Medical School.
Faculty, fellows, researchers and students
from Harvard Medical School and from Dubai
and the UAE will suppor t the work at the centre.
Harvard Medical School (hms.harvard.edu) has
more than 9,000 full-time faculty working in 11
academic depar tments located at the school’s
Boston campus or in one of 47 hospital-based
clinical depar tments at 16 Harvard-affiliated
teaching hospitals and research institutes.
K N O W I N G M AT T E R S .
DICOM DATA
IS JUST THE
BEGINNING.
Today, healthcare enterprises must manage PDFs,
TIFFs, MPEGS and other non-DICOM data types.
However, conventional VNAs can only store DICOM
data – with all other types housed in isolated silos.
Vue Vendor Neutral Archive is proven to ingest both
DICOM and non-DICOM data into a central archive,
from which it can be accessed by all through a
universal viewer.
V U E . K N O W I N G M AT T E R S .
© Carestream Health, Inc., 2014. CARESTREAM is a trademark of Carestream Health.
Learn more at carestream.com/vna
#arabhealth
@arab_health
13
ARAB HEALTH daily dose
BRINGING THE INDUSTRIAL REVOLUTION TO
HEALTHCARE DESIGN AND PROCUREMENT
Article provided by KEF-TAHPI Design Studio
H
ealthcare currently consumes a large
proportion of the total Gross Domestic
Product (GDP) of every country. For
the last three decades, this cost has been steadily
rising, often faster than the overall growth of the
economy. Many countries already have a substantial
deficit in healthcare funding. A significant part
of the cost is in the design and construction of
healthcare facilities.
To compound the problem, developing
countries are experiencing a boom in urbanisation,
growing middle class, increasing life expectancy,
the ageing of the population, increasing awareness
of health issues, and expectations of improved
healthcare. Today’s healthcare demand is a
challenge, let alone the future demand of the
future’s procurement cost.
CLEARLY, WITHOUT A MAJOR
CHANGE, HEALTHCARE
IS INCREASINGLY
UNSUSTAINABLE
Private hospital profit margins become increasingly
slim, insurance premiums become un-affordable
and governments are forced to choose between
health, education, roads, security, and other public
services.This is not theory. It has already happened
in many countries with mature healthcare systems.
Given this inevitable crisis, a major change
may come from re-examining what is the core
mission of a healthcare facility. We submit that it
is what the name suggests: Health Care. Such care
needs to be provided as quickly and as efficiently
as possible. Healthcare facilities are effectively
machines for healing and maintenance of the
body. They need to have the right elements, be
patient- and staff-friendly but not necessarily
opulent or extravagant. Healthcare facilities are
not hotels with equipment bolted on. For that,
there are many excellent real hotels and resorts.
They are not someone’s home to be designed
and decorated to their personal taste. They
need to perform critical functions just like the
hi-tech equipment they contain. They do need
to provide for a wide range of people, cultures,
age and gender. They need to be safe and trusted
rather than subject to hit and miss depending on
numerous people and the companies involved,
such as the client representatives, designers,
project managers, builders, and equipment
suppliers. Just one or two of the above may
be the weak link in a chain that can fail with
catastrophic costs, both in monitory terms and
in healthcare outcomes. We must overcome this
variable outcome due to the prevalent do-ityourself procurement methodology.
OUR CONCEPT
The KEF-TAHPI Design Studio, in Dubai’s
Healthcare City, visualises a world where
healthcare facilities are of predictable, high quality.
They improve every year whilst getting cheaper
to deliver, maintain and operate. They would look
like confident and proud, with brand recognition.
Looking around for solutions, one finds numerous
examples such as computers, cameras, and cars.
Apart from constant improvement in features,
looks and usability, they are the same price or
cheaper today than ten, or even 20 years ago.
These are products of industrial design,
innovation and production on a large scale.
Industrial revolution produces such products
in many fields with incredible precision and
attention to safety, such as high-speed trains and
plains. At the KEF-TAHPI Design Studio we have
been planning for more than 15 years to deliver
healthcare facilities using industrial techniques.
This involves a two-part approach, ‘Soft
Modular’ and ‘Hard Modular’.
Soft Modular is about the compartmentalisation
of the knowledge of healthcare design into units of
planning from departments and services down to
rooms, content, finishes and specifications.
An information catalogue of 50 functional
units of planning plus 500 unique rooms
types, each fully specified, pre-designed and
engineered with multiple permutations can
be used to create hospitals of any size or
Image © KEF-TAHPI Design Studio
14
facebook.com/arabhealth
specialisation. These form the raw components
of rapid design. Each component would be
fully audited to comply with all the relevant
standards and guidelines out-of-the-box.
These elements could then be used for
healthcare projects from refurbishments and
extensions and new facilities. It would be a matter
of choosing the right elements rather than reinventing every element every time for every
project. The KEF-TAHPI Design Studio has been
established just for this purpose.
The KEF –TAHPI Design Studio goes even
further. Using the same components, we offer six
categories of complete hospital designs from the
smallest rural and remote hospitals with 15 to 18
beds to major metropolitan teaching hospitals
with 500+ beds and all required facilities. These
entire hospitals would also be fully designed
and engineered with a small range of possible
customisations.
Hard Modular takes these modular designs,
then pre-fabricates them in components and
delivers them through the industrial efficiency of
scale with consistent quality. These will be available
at a substantially lower cost than the traditional
procurement methods. They replace ‘construction’
with ‘transportation’ and ‘assembly’. They would be
fully functional at the time of delivery with nothing
missing for full operation including all medical and
non-medical equipment, furniture, software and
automation systems. In short these are hospitals
delivered like large passenger aircraft. They will
be known by capacity, model and the KEF-TAHPI
brand. They will come with a warranty like any
industrial product.
TAHPI has been at the forefront of healthcare
design for decades, not only delivering hundreds
of facilities but also authoring the healthcare
standards and guidelines of many countries.
TAHPI is also the developer of a vast range of
automation software for healthcare briefing,
planning and design management. KEF is a major
industrial group with two pre-fabrication factories
in India and the UAE, delivering all the components
required for healthcare facilities. These include fully
precast concrete structure, room pods for small
rooms and flat-pack wall and components for
larger room types.
KEF-TAHPI currently guarantee the delivery of
healthcare projects at 20% less cost and 30% less time
than the lowest traditional delivery method. Within
five years, KEF-TAHPI aim to achieve 50% cost and
time reduction for all projects compared with a QS
estimate for the traditional procurement methodology.
WHAT’S THE CATCH?
So, one might ask what is the catch? What is
the disadvantage? The answer is simple. Clients
would not uniquely own the design. Just like
cars and planes they simply receive the ‘product’.
Design and engineering will effectively be at no
cost. Furthermore, they will be trading infinite
variability and personal design preferences
with selection from a design catalogue. These
catalogue hospitals will come with a limited range
of options and choices such as finishes, cladding
types and branding elements. Effectively clients will
be exercising their own creativity by choice in a
showroom environment.
There are many projects underway at any given
time, designed under the traditional, slow and
variable processes. It is not too late for these to be
delivered under the KEF-TAHPI industrial system.
The KEF-TAHPI Design Studio can convert any
existing plans into the modular equivalent, ready
for delivery and assembly. Although this solution
will not be as efficient as the six fully designed
modular hospitals, nevertheless they will provide
substantial cost and time saving.
The catalogue of KEF-TAHPI’s six classes of
modular hospitals including numerous samples of
individual departments and room types is available
for viewing at the Design Studio as well as the
KEF-TAHPI showroom at Arab Health 2015. The
showroom incorporates three standard room
types including a bedroom, bathroom and utility
room. These represent the quality expected of
the KEF-TAHPI brand.
TUESDAY 27 January 2015
#arabhealth
@arab_health
15
ARAB HEALTH daily dose
BRIDGING THE GAP:
MEDICAL EDUCATION
By: Dr Amer Ahmad Sharif, Managing Director – Education, Dubai Healthcare City
Dubai Healthcare City
introduce its first
medical university
12 successful years. Today, Dubai Healthcare
City (DHCC) draws the attention of not only
medical professionals across the spectrum of
medicine, allied health and complementary
medicine, but students who wish to pursue
careers in healthcare.
Medical education has been our parallel
agenda, our bedrock, solidifying our effor ts to
bridge gaps in medical education.
When we speak of bridging gaps we address
these challenges:
 Access to high quality medical education and
research
 Suppor t for medical specialities in relation to
disease patterns in the UAE
 Developing a sustainable workforce in the
UAE and the region
 Increasing capacity of healthcare professionals
The most recent bridge we have built is the
Mohammed Bin Rashid University of Medicine
and Health Sciences (MBR-UMHS), the first
medical university in Dubai Healthcare City,
located at the Mohammed Bin Rashid Academic
Medical Center (MBR-AMC).
The MBR-UMHS, in vision, will give Emiratis
and expatriates, access to high quality medical
education, and introduce curricula to equip
future healthcare professionals with specialty
knowhow to treat diseases that afflict our
population.
The establishment of the MBR-UMHS
implements the UAE National Agenda, which
covers the sectors of education and health,
to achieve the UAE Vision 2021. It also, in
philosophy, interprets the community’s hopes
and aspirations for a promising future, as per
the strategic developmental aims outlined in the
Dubai Plan 2021.
The first phase of the Mohammed Bin Rashid
University of Medicine and Health Sciences will
include two colleges - the College of Dental
Medicine which is already established and offers
post-graduate dentistry programmes, accredited
by the Ministry of Higher Education and Scientific
Research (MOHESR), in collaboration with the
Royal College of Surgeons of Edinburgh (RCSE),
and the College of Medicine for undergraduate
medical students that will open for admissions
in September 2015. Currently, the College of
Dental Medicine has 53 residents.
Through accredited undergraduate and
postgraduate programmes, the MBR-UMHS will,
over the next few years, work with the upcoming
Mohammed Bin Rashid University Hospital.
The Hospital will provide the necessary clinical
training environment for medical students,
residents, and postgraduate students.
In phases, the university will add accredited
programmes, and introduce more colleges
including allied health sciences, nursing and
midwifery, Public Health and pharmacy.
As an Emirati, it is a development that fills me
with pride. We are grooming the future talent
of homegrown physicians to serve the future
healthcare needs of our nation and the region,
and bridging the generation gap in the process.
Dr Amer Ahmad Sharif,
CLEVELAND CLINIC’S
INTERNATIONAL EMERGING LEADERSHIP FELLOWSHIP
T
he International Emerging Leader
Fellowship, an innovative immersion
leadership programme has been
announced by Cleveland Clinic, Ohio, US. The
programme gives organisations the opportunity
for rich talent pipeline development in one of
the following concentrations: Finance, Patient
16
facebook.com/arabhealth
Experience, Human Resources, PatientCentred Medical Home, Nursing, Marketing,
Information Technology and Operations.
Do you have high potential midlevel
physicians, nurses or administrators who are
poised to meet your organisation’s demands?
Benefits of programme are an implementable
capstone project and unparalleled twomonth experience at a world-class healthcare
organisation. This competitive programme is
offered twice annually. Contact Christina Barss,
MS, MEd. [email protected].
For more information, please visit Cleveland
Clinic’s stand at CB127.
TUESDAY 27 January 2015
LESAFFRE’S NEW RANGE OF PROBIOTIC YEASTS
AND BACTERIA ON SHOW AT ARAB HEALTH 2015
L
ESAFFRE HUMAN CARE, the human
health and nutrition division of the French
group LESAFFRE, will be showcasing its
probiotic yeasts and bacteria marketed under the
Lynside® Pro and Probisis® brands at Arab Health
and Medlab 2015.
Images © LESAFFRE HUMAN CARE
LYNSIDE® PRO IS A RANGE
OF PROBIOTIC YEASTS
Lynside® Pro SCB, Saccharomyces cerevisiae var.
boulardii, is the world’s most widely studied and
documented probiotic yeast. It reduces diarrhoea
and reinforces intestinal health
Lynside® Pro GI+, is a Saccharomyces cerevisiae
strain, selected and patented by LESAFFRE, from
amongst thousands of proprietary strains, for its
effects against abdominal pain and intestinal bloating
and its ability to reduce intestinal discomfort. The
many successful preclinical and clinical trials carried
out on Lynside® Pro GI+ will lead to communications
in scientific conferences and publications in
international journals.
LESAFFRE HUMAN CARE will also be
displaying Probisis® BS, a new specific probiotic
strain, patented and clinically tested to strengthen
the body’s natural defences against harmful external
factors. This Bacillus subtilis was specially selected
and studied for its immune-stimulating properties.
The spore-forming ability of this strain offers
many benefits including a high stability at ambient
temperature in its original packaging as well as in
dose form under drastic conditions. Probisis® BS
can also withstand passing through the gastrointestinal tract thereby making it more effective in
the intestines.
The pre-clinical trials and clinical trials carried out
successfully on Probisis® BS have proven its ability to
significantly heighten the immune defences of seniors
in particular and protect them from infection.
Benoît Laplaize, Sales Manager at LESAFFRE
HUMAN CARE states “The Middle East is very
active and we have identified a high need for our
products in these markets. We intend to use our
first participation at the Arab Health Exhibition
as a means of gaining insight into the business
practices of the region and thereby secure new
opportunities.”
LESAFFRE HUMAN CARE manufactures and
sells bulk ingredients and probiotics in various forms
(capsules, blister packs and pouches) to formulators
and importers of ingredients and finished products.
These products are intended for companies in the
nutritional supplements and medicines sectors.
MORE INFO
Lesaffre Human Care is exhibiting at the
UBIFRANCE French Pavilion in Za’abeel Hall 2,
stand Z2F32.
We Will Place You “Right Ahead-Of-The-Curve”…
We are an Extended Global Network of Professional Market Access Teams
We are Dedicated to the Effective Regulatory Registration of Your Medical
Technology in Middle East and North African (MENA) Markets
We Will Place Your Product Right in the Market in a Record Time
We Will be Your Authorized Representative Across All the Key Markets
We Will Secure Your Product Marketing Authorization and License
Renewal in a Speedy and Unparalleled Manner
We Strictly Observe Ultimate Confidentiality and Code of Ethical
Business Conduct in Everything We Do
For More Information on Our Portfolio of Services That Are Tailored to Meet Your Particular Needs, Please
Contact Us and Our Team of Consultants Will Be Happy to Assist You:
Email:[email protected]
[email protected]
[email protected]
[email protected]
[email protected]
[email protected]
Tel: +971 4 430 8474
+971 55 381 1004
+971 56 901 2159
+971 50 782 8723
+971 56 726 9822
+971 50 559 5246
Website: www.axessgulf.com
1412 Burj Khalifa Street, P.O. Box 232717
Dubai, UAE
Our Global Affiliates:
USA: Axess LLC P.O. Box 54048 Irvine, California 92618 Tel: + 562 - 810 - 3583, www.axesshc.com – [email protected]
KSA: Health Horizon Est. 7177 King Abdulaziz Road, Al Yasmeen, Riyadh, Saudi Arabia, www.healthhorizon.center – [email protected]
#arabhealth
@arab_health
17
ARAB HEALTH daily dose
UTAH IS THE GATEWAY FOR MEDICAL COMPANIES
LOOKING TO TAP THE AMERICAN MARKET
A diverse economy and widely recognised medical products
make Utah the best choice for healthcare companies
K
nown worldwide for its medical products
and diagnostics, the US state of Utah
is home to more than 1,000 medical
companies and is the gateway for foreign medical
businesses looking to tap the healthcare market
in the United States. Several Utah companies will
be in Dubai to represent Utah’s strong medical
legacy at this year’s Arab Health. Some of the
companies will be showing in the Utah stand
alongside government officials. These companies
are Summit Medical Products, Inc., Novarad
Enterprise Imaging Solutions, Arlington Scientific,
Inc. (ASI) and Megadyne Medical Products.
Maxtec and Varian Medical Systems will also be
showing independently at the conference.
Utah recognises the importance of the life
science industry, which includes a focus on medical
devices, pharmaceuticals, natural products, diagnostics,
equipment and reagents. It is one of the state’s
strongest industries, employing more than 30,000
employees with an average wage of US$63,839
(150% above the state average). The strength of
this industry and its wide recognition of top-notch
medical products and diagnostics motivate many
medical companies to locate to Utah.
“Life sciences companies in Utah positively
impact people worldwide”, said Val Hale,
Executive Director of the Utah Governor’s
Office of Economic Development. “Companies
in the medical field have great access to financial
resources as well as high-profile IT and software
businesses to support their leading-edge
innovation, and there’s room for new companies
18
to grow.”
Utah is a one-stop shop for medical
companies. The state is strong in all areas of
the healthcare industry, with research and
development centres, medical testing and
contract manufacturers. The Governor’s Office
of International Development’s State Trade and
Export Promotion (STEP) is leading the Utah
stand with a cooperative agreement with the U.S.
Small Business Administration.
The strength of the life sciences industry in the
state, as well as the strength of its financial sector
and advancements in information technology,
harbour a stable economic environment and help
earn the state the title of ‘Forth Most Diverse
Economy’ in the United States.
“Utah’s economic environment and skilled
workforce make Utah the best place for
medical companies to do business and offers a
promising market for foreign direct investment
opportunities”, said Director of Utah’s
International Trade and Diplomacy Office, Brett
Heimburger, who is also attending the conference.
One of the companies attending Arab Health
is Summit Medical Products. They develop,
manufacture and market high-quality devices
to increase utilisation of infusion therapy.
The company sells products worldwide and
is supported by a team of professionals from
engineering, manufacturing, regulatory affairs,
marketing and sales. Summit Medical
Products have international distributors and
representatives throughout Europe, the Middle
facebook.com/arabhealth
East, Africa and other countries.
Novarad Enterprise Imaging Solutions,
another company representing Utah’s medical
market this year, focuses on creating medical
products to improve radiology efficiencies and
productivity. The company evaluated years of
input from customers, radiologists, Integrating
the Healthcare Enterprise (IHE) and members of
the Novarad Board to improve their radiology
products. Novarad currently has offices in the US,
England, Turkey and India.
The third medical company attending the
exhibition is Arlington Scientific, a leading global
medical technology company with more than
30 years of medical device manufacturing and
distributors in more than 40 countries. The
company develops, manufactures and sells in vitro
diagnostics, medical devices, diagnostic instrument
analysers and blood donor lounge chairs. They
work to enhance the speed of infectious disease
diagnoses and have particular expertise in digital
analysers, syphilis testing and more.
Megadyne Medical Products is also attending
the exhibtion. The company is an end-to-end, fullsolution electrosurgical equipment and accessory
developer and manufacturer. The company’s
mission is to provide high quality, cost-effective
products to surgeons, nurses and hospitals.
Companies interested in doing business in
Utah should visit the stand at this year’s Arab
Health.
More information can be found at
business.utah.gov.
TUESDAY 27 January 2015
Making the difference with
Philips Live Image Guidance
Philips AlluraClarity with the unique ClarityIQ technology is a revolutionary new
generation of X-ray systems that provide high quality imaging for a full range of clinical
procedures at ultra low dose levels. Designed in close collaboration with leading
clinicians in the field of minimally-invasive medicine, AlluraClarity is a quantum leap
forward for your interventions, giving you exceptional live image guidance.
Visit us at Arab Health booth # S2C10
RK41590
Discover the difference for you at
www.philips/com/AlluraClarity
Delivering Better Health in the Middle East
The first hospital in the Middle East to be awarded Joint Commission International Accreditation (JCI)
The first private laboratory to be certified by the College of American Pathologists (CAP)
Scope of Services at American Hospital Dubai
• Ablation Therapy
• Anesthesia
• Audiology
• Cochlear Implant
• Cardiac Surgery
• Cardiac Catheterization
• Cardiology
• Cardiopulmonary
• Dermatology
• Dietary Counseling
• Endoscopy
• ENT Surgery
• Gastroenterology / Hepatology
• Hematology
• General Surgery
• Internal Medicine
• Medical Imaging
• Minimally Invasive Surgery
• Nephrology / Dialysis
• Neurology
• Neurosurgery
• Obstetrics / Gynecology
• Oncology / Chemotherapy
• Ophthalmology
• Orthopedics
• Diabetes / Endocrinology
• Pathology & Laboratory
• Pediatrics (Children)
• Pediatric Allergy and Asthma
• Pediatric Surgery
• Primary Care
• Rheumatology
• Sports Medicine & Physical Therapy
• Urology
• Vascular Surgery
• 24 Hour Emergency Service
ahdubai.com
#arabhealth
@arab_health
19
ARAB HEALTH daily dose
THE BUILDING OF A HEALTHCARE CONGLOMERATE:
A STORY RETOLD
Article provided by Aster DM Healthcare
H
ealth is weighed more in the world today
and people tend to care for even the
smallest of ailments. Here, we tell the story
of a man who has single-handily built a conglomerate
in the healthcare sector.
Dr Azad Moopen, Chairman and Managing
Director of Aster DM Healthcare, spearheading
the conglomerate of medical and paramedical
institutions spread across the Middle East and India,
truly has a magical touch. Today the healthcare
conglomerate encompasses medical colleges,
hospitals, clinics, diagnostic centres and pharmacies
in the Middle East and India. All these have flourished
from this Land of the Golden Sand, where futuristic
visions have always prospered.
The maxim that guides the Group is ‘Care
beyond boundaries’. More than 8 million patients
stand a testimonial to this principle. The brands
of Aster DM Healthcare, Aster, Medcare, MIMS,
Aster MedCity, Access, and DM-WIMS are
arrayed under the group. Dr Moopen plans to
increase the present capacity of 1,700 beds to
5,000 by 2017. As for the various institutions
under the group, the target is to increase the
present numbers of 175 to 300 by 2015.
THE SUCCESS SAGA
Dr Moopen began his career in India as a lecturer of
Internal Medicine at the Calicut Medical College in
Kerala. He has an admirable academic background;
MBBS with gold medal, MD in General Medicine and
a Diploma in Chest Diseases from Delhi University.
Back in 1987, Dr Moopen started his first clinic in
Bur Dubai, in response to the growing demand for
quality healthcare in the region. The dedication and
quality of service he rendered scripted the rest, a
well-knitted network of institutions catering primarily
to quaternary care across the Middle East and
India. The popularity and reputation of the Group
amongst the non-resident Indian (NRI) community,
paved way for spreading its services to India.
Operating under the umbrella of Aster DM
Healthcare, the Medcare Hospitals, with their
cutting-edge technologies and talented multi-ethnic
healthcare professionals, are widely acclaimed in the
Middle East. The Aster Medical Centres, known for
their clinical acumen, make medical care accessible
and affordable to a larger section of people in
UAE. The Aster Diagnostic Centres and the Aster
pharmacies, having presence in all the seven
countries, support the Group with quality diagnostic
services and supply of pharmaceutical and nonpharmaceutical products.
In India, the 600-bed Malabar Institute of Medical
Sciences (MIMS) in Calicut and the 150-bed MIMS
Hospital at Kottakkal in Malappuram were the initial
ventures. The ASTER – Aadhar Hospital, a multispeciality hospital at Kolhapur in Maharashtra with
175 beds and Aster Medpoint Hospital at the Aundh
locale in Pune are coveted centres of medical care
in Northwest India.
The newly opened ASTER Medcity in Kochi is
a premium project in Asia, offering 670 beds in its
first phase. This project is a combination of superspeciality hospitals, or Centres of Excellence. The
second phase of the Aster Medcity will see another
500 beds added.The institute is growing popular, not
only amongst the NRI community in Kerala, but also
Image © Aster DM Healthcare
20
facebook.com/arabhealth
in the MENA and SAARC regions, making it a health
tourism hotspot thanks to cost-effective care. It truly
lives up to its core philosophy of ‘We will treat you
well’.
Aster DM Healthcare is a healthcare
conglomerate, unique by its multi-vertical platforms,
offering multiple brands in multiple geographies.
CARRYING THE TORCH FOR
THE FUTURE
Coming from an academic background, education
is always close to Dr Moopen’s heart. He strongly
believes that he must contribute to the steady
stream of new healthcare professionals and has
started many institutions to strengthen this area.The
DM Wayanad Institute of Medical Sciences (DM
WIMS) in the Wayanad district of Kerala, admits 150
MBBS students yearly.
The MIMS Academy Trust trains a large number
of students in various disciplines of medical,
paramedical and nursing areas. The MIMS Research
Foundation, also a constituent of the Trust, is leading
a dedicated line in medical research. Nurturing the
young through quality education has also been
important to Dr Moopen, establishing several
international schools in the UAE, Saudi Arabia and
India, with plans to open more in future.
NEW ENDEAVOURS
In the UAE, the 100-bed Aster Hospital in Mankhool,
Bur Dubai, is the prime new project of the Group.
Two other projects, the 75-bed Medcare Palace
Hospital on Sheikh Zayed Road, Dubai and the 115bed Medcare Hospital in Sharjah are scheduled to
open next year. Hospitals in Abu Dhabi and Ajman
are in the inception stage and another one being
developed in Qatar is scheduled for launch in 2015.
The MIMS in Kerala is set to open its new
ventures in the Malabar region. With a focus to
emerge as a leading healthcare service provider in
India, Aster DM Healthcare is planning to set up
hospitals in four states in the southern and western
regions of India.
SOCIAL RESPONSIBILITY
– IN PROFESSIONAL AND
PERSONAL LIFE
Along its course of growth, Aster DM Healthcare
is contributing to the welfare of those in need.
Apart from the caring service it renders for ailing
patients, the Group has also undertaken several
social responsibility activities. Dr Azad Moopen
himself is at the forefront, contributing a major
portion of his personal wealth for the initiatives. The
DM Foundation under Dr Moopen is supporting
numerous social welfare and charity activities.
Throughout the journey, his endeavours have
him yielded success and well-deserved credits.
The Government of India had bestowed him with
the Padma Shri, the third highest Civilian Award in
2011 and the Pravasi Bharatiya Samman Award in
2010, the highest honour conferred to non-resident
Indians. Arab Health honoured Dr Moopen in 2010
for his outstanding contributions as an individual to
the healthcare industry in the Middle East. Many
accolades, both national and international, have been
awarded to him in recognition of his remarkable
service to humanity.
l InSightive Analytics, a new interactive dashboard that organises and
presents information in a simple display for easy decision making. This
tool will enable oncology professionals
to more
capitalise
TUESDAY
27effectively
January 2015
on their data in Varian’s ARIA® oncology information system*
VARIAN MEDICAL SYSTEMS ANNOUNCES
Medical Systems
LATEST ADVANCESImages
IN© Varian
CANCER
TREATMENT
Article provided by Varian Medical Systems
V
arian Medical Systems, the world-leader
in radiotherapy treatment systems and
software, is highlighting a number of
advances during the Arab Health Exhibition &
Congress. The company focus on software and
services that enable information sharing and
data analytics to support more efficient, higherquality cancer care. “We are unveiling some
new, interconnected software products aimed
at improving efficiency, quality, and consistency
of care in cancer clinics around the world”, said
Kolleen Kennedy, president of Varian’s Oncology
Systems business. “We’re particularly excited
to be offering a first glimpse of our new cloud
community, where users of Varian technology can
share information and experience.”
Varian highlights
 The TrueBeam™ and Edge™ platforms for
image-guided radiotherapy and radiosurgery. Early
adopters of the Edge system report that they are
using it to deliver treatments for cancer of the lung,
liver, brain, and spine, which require careful, precise
targeting that compensates for motion during
treatment

InSightive™ Analytics, a new interactive
dashboard that organises and presents information
in a simple display for easy decision making. This
tool will enable oncology professionals to more
effectively capitalise on their data in Varian’s ARIA®
oncology information system*

Qumulate™ QA, a cloud-based quality
assurance data management and analysis tool for
analysing and benchmarking linear accelerator
quality assurance (QA) performance*

Velocity™ oncology software for compiling
patient images and treatment data from a variety
of sources to support more informed decisionmaking

RapidPlan™ knowledge-based treatment
planning, a software tool that uses historical
treatment plan data to increase plan quality and
streamline the treatment planning process.
“For Varian, helping customers aggregate
data, pool knowledge, and learn from each
other has become imperative, as more and
more treatment centres seek effective ways of
implementing precise, non-invasive treatments
like image-guided radiosurgery”, says Chris
Toth, Vice President of Global Marketing for
Varian’s Oncology Systems business. “Our goal
with many of our new products and services
is to help our customers turn data into usable
information on how to treat patients, and
then to collaborate in making that knowledge
actionable in a meaningful way.”
Particularly popular at the show was InSightive
Analytics, which will enable users of Varian’s
ARIA® oncology information system to quickly
access, organise and analyse data captured during
clinical and administrative operations in radiation
oncology, to help drive better clinical decisionmaking and outcomes.
“ARIA is a robust practice management
system and electronic medical record with a
tremendous amount of information that can be
mined and analysed to enhance the quality of care
and the efficiency of clinical operations at any
given site”, says Sukhveer Singh, Vice President of
Varian’s Oncology Continuum Solutions. “Many
customers use ARIA to become paperless
clinics, so all the information that once went
into paper char ts is now entered into the ARIA
system. ARIA also offers many interfaces for
impor ting data from other hospital information
systems, resulting in a very rich resource that,
up to now, was difficult to mine for actionable
knowledge. InSightive Analytics provides access
to this data, making it visible and useful.”
InSightive Analytics will enable users to
discover impor tant patterns and trends
quickly so they can make more informed datadriven decisions. Users can pre-programme
dashboards to generate repor ts on a routine
schedule. Graphs and tables can be expor ted
for presentation. According to Singh, it will be
especially useful for cancer centre administrators
who need to manage resources.
Varian also spotlighted its progress in the
growing field of proton therapy, with an update on
the clinical rollout of the ProBeam™ system at the
Scripps Proton Therapy Center in San Diego, as
well as the launch of a one-room proton solution
called ProBeam Compact.
MORE INFO
Visit www.varian.com for more information.
*Works-in-progress and not yet available for sale
Image © Varian
200
ARAB HEALTH MAGAZINE SHOW ISSUE 2015
#arabhealth
@arab_health
21
ARAB HEALTH daily dose
DR. SULAIMAN AL HABIB MEDICAL GROUP AND
AVAYA DEMONSTRATE REGION’S FIRST MOBILE
EMERGENCY HEALTHCARE SERVICE
D
r. Sulaiman Al Habib Medical Group
(HMG) and Avaya, a leading provider
of solutions that enable customer and
team engagement across multiple channels
and devices, yesterday announced their joint
par ticipation at the Arab Health Exhibition and
Congress 2015. The two companies have joined
effor ts to launch the first mobile healthcare
environment in the region designed to instantly
respond to field emergency conditions, and
enable medical professionals to remotely save
the lives of patients in a critical condition.
HMG, Avaya and Cloud Solutions, a
regional IT solutions provider and an Avaya
par tner in the Kingdom of Saudi Arabia, have
built and tested a number of other mobile
healthcare applications that will be on show
at Arab Health, using Avaya Smar tEngage, a
tailored combination of Avaya and third-par ty
solutions and ser vices, designed to enable
engagement between teams and patients,
from anywhere, using any mobile, computing
or wearable device.
Nasser Al Huqbani, CEO of Dr. Suleiman
Habib Medical Group said that the videoenabled solutions developed for field
emergency services will deliver remote
diagnostic and treatment quickly and efficiently,
especially in extreme emergency cases. Medical
staff in ambulances will be able to have a direct
communication with emergency staff based
in the hospital for immediate suppor t, and to
ensure that the ICU and emergency teams are
ready to ready to receive the patient as soon
as he or she arrives to the hospital, ready for
immediate care.
HMG will be also demonstrating a number
of mobile solutions designed to deliver a
22
GBUK LTD
MEETS RT HON
EARL HOWE AT
ARAB HEALTH
G
Habib Medical Center doctor using Google Glass in an
ambulance to solve emergency scenarios while on the move”
seven star experience and convenience to
its patients. Using self-service, video-enabled
kiosks connected to the group’s regional call
centre, patients will be able to walk into any
HMG facility in the region and interact with a
self-service, video-enabled kiosk, connected to
the group’s regional call center and services.
Patients will be able to initiate and complete
their transactions by video, vir tual collaboration,
email, social media, chat, SMS or phone, and to
even switch between devices or channels while
talking to the same HMG call centre agent.
facebook.com/arabhealth
Mobile healthcare services being demonstrated
at Arab Health include self-service registration,
scheduling
of
appointments,
insurance
registration and validation, printing of medical
repor ts such as laboratory and radiology
results and prescriptions. The group will be
able to deliver the same and additional services
via vir tual, self-service healthcare branches
anywhere in the future, without the need for
patients to physically walk into an HMG facility,
bringing healthcare services closer to patients
quickly, easily and securely.
BUK Ltd, one of the UK’s market
leaders in enteral consumables,
met with Rt Hon Earl Howe
during his tour of the UK Pavilion at the
opening day of Arab Health.
Earl Howe, who is the Parliamentary
Under Secretary of State for Quality,
spoke to GBUK Ltd Group Marketing
Director Marcus Ineson, about the
support they had received from the UKTI,
which has seen the company put in touch
with specialists from different markets.
After Marcus highlighted the desire
for the company to build momentum,
Earl Howe assured the team that GBUK
was in the right place exhibiting at Arab
Health.
Earl Howe said, “This is my third
year out here and I sense that there is
a real momentum here at Arab Health.
There is a real desire by the Emirates to
move ahead in a way that they haven’t
before. They look at trusted companies
from overseas - trust and relationships
matter in this market. Evidencing that you
have a product or service that is in use
in recognisable places will mean you are
pushing at an open door.”
GBUK Ltd will be located at Stand
Z1G57 in the Za’abeel Hall for the
duration of the show, and will exhibit
its products including enteral syringes,
nasogastric tubes and dilators – all
available with the new ISO connector.
TUESDAY 27 January 2015
“Everything we do,
we do with passion –
and we do it
for life.”
Stefan Dräger, Chairman of the Executive Board
Arab
s at t he
Visit u
: SHK.
Located
2015
Healt h ooth S3D30
all 3, B
Saeed
H
5415
www.draeger.com/arabhealth
#arabhealth
@arab_health
23
ARAB HEALTH daily dose
MULTIMODALITY APPROACH TO BREAST CANCER
A
t a South African practice, a dedicated
team of medical experts work together
to detect and fight breast cancer using
different imaging modalities
Considering that breast cancer is the number
one cancer amongst women in South Africa, its
early detection may have reduced mortality in
recent years. However, South Africa does not have
an official breast cancer-screening programme.
Nonetheless, the first Siemens Mammomat®
Inspiration PRIME mammography system for clinical
use was installed at a practice, Capital Radiology,
in South Africa, which follows a multi-disciplinary
approach to breast imaging. Here, a range of dedicated
and experienced specialists, radiologists, radiographers,
surgeons, radiation and medical oncologists work
together with one aim: Breast health.
A LARGE CATCHMENT AREA
assessing dense breast tissue. If a mammography
or ultrasound exam shows a suspected cancer,
biopsies are carried out under either stereotactic
mammography guidance or ultrasound guidance.
A multidisciplinary team of surgeons, oncologists,
and pathologists then decide the treatment path,
possibly involving other modalities such as MRI,
computed tomography, and, in some cases PET-CT,
in this process. For example, MRI is used for breast
cancer screening in high-risk women, as a problemsolving tool for equivocal mammographic findings,
to assess patients with newly diagnosed breast
cancer before surgical procedures or to evaluate
patients with positive surgical margins following
breast conservation therapy.
that alone justifies the investment we have made,
because it is the best for the patient, with optimum
comfort and accurate diagnosis.”
Dr Eugene Jooste, Partner Radiologist at Capital
Radiology, also specialises in mammography. Dr
Jooste says the new system provides an improved
experience for the patient because time-consuming
tasks become quick and simple, giving more time
to the radiologists to meet the patients and talk
to them. “The ‘Eureka moment’ is when we see
nothing questionable on the image and are able to
say that all is well.“
DIAGNOSIS WITHOUT DELAY
The new mammography system has enabled the
practice to increase the volume of patients screened.
The results are made available immediately at
Capital Radiology rather than patients having to
go home and wait for days for a phone call. “The
doctors are dedicated and because they do this
every day, they know what they are seeing on an
image. If they decide that a biopsy is needed, it is
done without delay directly after the mammogram“,
highlights Marlette Robbertse, Head Radiographer
at Capital Radiology.
SIEMENS IS A LONG-TERM
PARTNER
The private practice is situated at the Little Company
of Mary Hospital (LCM) in leafy Groenkloof, a
suburb of Pretoria. Every month literally hundreds
of women walk through the practice’s doors to be
screened for breast cancer. Patients are sometimes
even referred by general practitioners in other
provinces of South Africa. As a private radiology
practice, Capital Radiology is usually reimbursed by
insurance and out-of-pocket payments.
The radiologists and radiographers at Capital
Radiology are at the forefront of developments
in technology and procedures to fight the most
prevalent cancer in the country. “That is why we are
the Siemens flagship practice in South Africa”, says
Piet Oberholzer, MD, Senior Partner and Consultant
Diagnostic Radiologist at Capital Radiology. ”We
trust Siemens as a long-term partner in serving our
community with the best available technology and
affordable care.”
BEST TOOLS FOR BREAST
CANCER DIAGNOSIS AND
TREATMENT
MINIMISED RADIATION
DOSE AND IMMEDIATE
RESULTS
Mammography can detect small, early-stage
tumours that cannot be felt by touch. In particular,
it detects micro-calcifications that may indicate
tissue changes and a preliminary form of cancer.
While mammography is still the standard diagnostic
tool for detecting breast cancer in its early
stages, the radiographers at Capital Radiology
also use ultrasound, which is especially helpful in
Minimising dose in mammography is extremely
important as healthy women are examined regularly.
The new system is therefore equipped with a
software-based anti-scatter solution. This and the
sharper images delivered are the most important
features of the new system. ”You can lower the
radiation levels up to 30% without having an impact
on the image quality”, says Dr Oberholzer. “And
A dedicated team of medical experts work together to improve breast cancer
Treatment in South Africa. Image provided by Siemens Healthcare
A91XP-9265-A3-7600
Visit us at
booth S1D10,
Sheikh Saeed
Hall 1
Cios Alpha
See the power with Full View FD
www.siemens.com/cios-alpha
The first mobile FD C-arm that always provides the
Full View, Cios Alpha delivers outstanding image
quality so that you can perform and evaluate your
procedures with even greater confidence.
system control with effortless precision while
integrating seamlessly into your surgical workflow.
Cios Alpha. See the power with Full View FD.
Capable of generating the power you need for
very challenging situations and long procedures,
Cios Alpha combines intuitive and convenient
Answers for life.
24
A91XP-9265-A3-7600_267x180.indd 1
facebook.com/arabhealth
04.12.14 14:20
TUESDAY 27 January 2015
Solutions for Improving
© 2015 Thermo Fisher Scientific Inc. All rights reserved. All trademarks
are the property of Thermo Fisher Scientific Inc. and its subsidiaries.
Patient Outcomes
Advert in Daily Dose-v10.pdf 1 2015/1/6 上午 01:20:19
C
M
Y
CM
MY
CY
CMY
K
#arabhealth
@arab_health
25
ARAB HEALTH daily dose
New feature brought to you by
26 – 29 January, Plaza Hall
In 1867, Sir Joseph Lister, British surgeon
and pioneer of antiseptic surgery, wrote
a series of reports for internationally
acclaimed medical journal The Lancet, which
dramatically changed the face of surgery to
give us the sterile environments in which we
operate today.
On display in the Future of Surgery Zone
is a rare original 1867 edition of the book
containing these ground-breaking reports
- a donation by USA exhibitors to the Al
Maktoum Medical library during Arab Health.
Documented
as seen,
in
Visit the Future of Surgery
Zone in the Plaza Hall to
see this incredible historic
artefact for yourself.
Brilliance in 3D documentation with
KARL STORZ AIDA®
· Latest technologies
· Innovation Hub
· Free seminars
OR1 52 09/2014/A-LB
Go to the Future of
Surgery Zone for:
KARL STORZ GmbH & Co. KG, Mittelstraße 8, 78532 Tuttlingen/Germany Telephone: +49 (0)7461 708-0, Fax: + 49 (0)7461 708-105, E-Mail: [email protected]
KARL STORZ Endoskope – East Mediterranean and Gulf S.A.L, Block M, 3rd Floor, Beirut Souks, Weygand Street, 2012 3301 Beirut/Lebanon,
Phone: +961 (1) 999390, Fax: +961 (1) 999391, E-mail: [email protected]
www.karlstorz.com
Cielo Healthcare is the leading provider of
Recruitment Process Outsourcing (RPO), Strategic
Recruitment Projects and Physician Hiring Solutions
to Healthcare organisations across The Middle East
and North Africa (MENA).
Our teams based in Dubai, Qatar, KSA and other key
MENA locations interface with Cielo Healthcare’s
world-wide network of offices to find, attract,
engage and hire critical local and global talent
for our dedicated Healthcare clients.
Eradicate recruitment agency usage, access the very
best global Healthcare professionals and save your
organisation money with an in-house Recruitment
Solution from Cielo Healthcare MENA.
www.cielotalent/HC | +971 (0) 4 279 6302
Recruitment Process Outsourcing | Physician Recruitment | Consulting
26
facebook.com/arabhealth
Moorland Gray, previously Carmichael Fisher
Middle East, is the largest and most successful
executive search firm in the MEA region having
delivered more than 1,000 searches in the past
eight years.
Moorland Gray has improved performance for
hundreds of healthcare clients across the region
and are the first port of call for Chairmen
and Chief Executives looking to strengthen
their leadership teams.
moorlandgray.com | +971 (0) 4 279 6300
TUESDAY 27 January 2015
ACHIEVE A
NEW PERSPECTIVE
Olympus 3D Imaging and THUNDERBEAT
Visit us on stand 3E30 at Arab Health 2015 showcasing
Olympus ENDOEYE FLEX 3D and THUNDERBEAT.
Follow us on Twitter @OlympusMedUIMEA
www.olympus.co.uk/medical
#arabhealth
@arab_health
27
ARAB HEALTH daily dose
Check in with Welch Allyn
during Arab Health 2015 to celebrate our 100th anniversary
and check out our latest breakthrough products and
technologies designed to enable frontline practitioners
to provide superior patient care.
Welch Allyn Booth
SAEED HALL 1 - S1B50
28
facebook.com/arabhealth
NEW PRODUCTS
TUESDAY 27 January 2015
EDDA TECHNOLOGY TO INTRODUCE THE IQQA® IMAGING-GUIDED
CANCER TREATMENT SOLUTION AT ARAB HEALTH 2015
E
DDA Technology, a global leading provider
in computer-assisted radiology and surgery
solutions is exhibiting at Arab Health 2015.
The company is showcasing its award-winning
IQQA® Platform and Product Suite, an innovative
technology platform in imaging-guided cancer
treatment.
The IQQA® Platform and Product Suite
provides real-time, quantitative multimodality
imaging solutions to support the entire patient
management cycle, including early detection,
treatment planning, intra-operative guidance and
monitoring, and post-operative follow-up. IQQA®
is currently being used by leading cancer centres
worldwide, including King Faisal Specialist Hospital
& Research Centre (KSA), Mayo Clinic (USA),
Massachusetts General Hospital (USA), University
of California San Francisco Medical Center (USA),
University of Colorado Hospital (USA), as well as
many other global luminary sites.
The company’s key highlight will be IQQA®BodyImaging, which extends the proprietary fast
and powerful 3D features in the IQQA® product
portfolio to thoracic, abdominal and pelvic scans.
Features such as virtual knife for surgery and virtual
needle for interventional planning, monitoring
and follow-up, provide comprehensive tools for
precision treatment delivery and quantifiable
patient assessment.
“We are excited to bring an offering that covers
close to 50% of the world’s cancer incidences
and also addresses key challenges related to the
treatment of prevalent lung and liver cancers in
the region to Arab Health”, said Dr Jianzhong Qian,
President and CEO of EDDA Technology, and fellow
of the American Institute of Medical and Biological
Engineering (AIMBE). “We are confident that the
IQQA® innovative solutions will aid in meeting
and exceeding the clinical needs and treatment
challenges in the Arab health market and abroad”.
As part of IQQA® Product Suite, the
company will also be demonstrating IQQA®-Liver
Multimodality and IQQA®-Chest. IQQA®-Liver
Multimodality has been proven to offer significant
time-saving and improved patient care for liver
cancer treatment in more than 15,000 cases
worldwide since 2009. IQQA®-Chest has been
shown in a prospective study to assist physicians
with early detection, by increasing physicians’
detection sensitivity of small lung nodules on x-ray
from 63.8% to 92.7%.
EDDA is exhibiting at stand Z4E27 in the US
Pavilion.
Images © EDDA Technology
IQQA® for thoracic, abdominal, and pelvic applications in cancer treatment planning, monitoring and follow-up.
Excellence in health care.
For more than 100 years, we constantly improved endoscopy
always provide you with the best tools for best results. Excellence in endoscopy. Curios
s an essential part of our company‘s culture: We just love to make things better. Excellence
innovation. We combine traditional craftsmanship with high-tech manufacturing to turn new ide
nto great products. Excellence in engineering. We know the best way to ensure qua
products is to make them ourselves. Excellence in quality. Less cables, more brains: O
network-based, integrated OR makes your work smarter, simpler and more secure. Excellence
integration. Our customer service strategy is simple: It’s our job to make yours easier. Excellen
ce in customer relations. Join our worldwide network of distinguished experts and supp
he medical progress. Excellence in education. Excellence in health care.
more than 100 years, we constantly improved endoscopy to always provide you with the best tools
best results. Excellence in endoscopy. Curiosity is an essential part of our company‘s cultu
We just love to make things better. Excellence in innovation. We combine traditional cra
manship with high-tech manufacturing to turn new ideas into great products. Excellence in eng
neering. We know the best way to ensure quality products is to make them ourselves. Excellenc
in quality. Less cables, more brains: Our network-based, integrated OR makes your work smar
simpler and more secure. Excellence in integration. Our customer service strategy is simp
&
t’s our job to make yours easier. Excellence in customer relations.
Join our worldw
network of distinguished experts and support the medical progress. Excellence in educatio
Excellence in health care. For more than 100 years, we constantly improved endoscopy
always provide you with the best tools for best results. Excellence in endoscopy. Curios
s an essential part of our company‘s culture: We just love to make things better. Excellence
innovation. We combine traditional craftsmanship with high-tech manufacturing to turn new ide
nto great products. Excellence in engineering. We know the best way to ensure qua
products is to make them ourselves. Excellence in quality. Less cables, more brains: O
network-based, integrated OR makes your work smarter, simpler
and
more
secure.
Excellence
Pay
us
a
visit
at
Stand
3G30
integration. Our customer service strategy is simple: It’s our job to make yours easier. Excellen
ce in customer relations. Join our worldwideand
network
of distinguished
discover
even more!experts and supp
he medical progress. Excellence in education. Excellence in health care.
Wolf at Arabprovide
Health – 26 -you
29 January
more than 100 years, we constantly improved endoscopyRichard
to always
with2015
the best tools
Discover the spirit
of excellence!
www.richard-wolf.com
175_14_ArabHealth15_175_125_EN.indd 1
K0
Y 91
M 100
C0
K0
Y 87
M 43
C0
C0
M 100
Y 91
K0
C0
M 43
Y 87
K0
Dubai International Convention & Exhibition Centre
#arabhealth
16.10.2014 16:43:26
@arab_health
29
Maquet 2015. All rights reserved. • Maquet reserves the right to modify the design and specifications
contained herein without prior notice.
INSIGHT
The Clinical Logistics Solution
IT solutions that deliver the right
information to the right people in real time
• Efficient workflows throughout the hospital
• Easy access to all relevant information
• Improved interdepartmental communication
• Four components: Emergency, Surgical, ICU, PatientWard
Maquet | The Gold Standard
Visit us in Sheikh Saeed Hall 2, booth no. S2G30 and
see how INSIGHT can streamline clinical workflows
INSIGHT Clinical Logistics – Improving workflow and patient
throughput in the OR, Emergency Department, ICU and Patient Ward
Workflow management is one of the greatest operational challenges facing hospitals today. Patients wait
in the Emergency Department while someone calls to
see if a bed is available on the patient ward. OR costs
skyrocket due to downtime from canceled procedures.
Hospitals have been lacking the insight into workflow
and patient throughput that delivers measurable economic benefits.
Visit Maquet: S2G30 in
Sheikh Saeed Hall 2
INSIGHT Clinical Logistics
hospital IT solutions
IT solutions that deliver the right
information to the right people in
real time
Patient Ward
IT solutions
for improved
overview,
communication
and coordination
Maquet recognizes the value of a comprehensive, easyto-use clinical logistics system that gives clinical staff
the information that they need to improve patient care.
INSIGHT Clinical Logistics features four components,
each specifically geared to the clinical area that it
serves: Emergency, Surgical, ICU and Patient Ward.
Maquet | The Gold Standard
ICU
INSIGHT Clinical
Logistics for the ICU
CSSD
T-DOC Link your hospital together. Monitor your business
and make the right decisions
Surgical
INSIGHT Clinical Logistics
improving surgical workflows
www.maquet.com
Maquet 2015. All rights reserved. • Maquet reserves the right to modify the design and specifications
contained herein without prior notice.
TEGRIS
Redefining OR Integration
The entire OR at your fingertips
• Modular solution
• High compatibility and future-proof investment
• Simplify workflows and boost efficiency
• Integration, documentation, communication
• All in one space-saving unit
Maquet | The Gold Standard
Visit us in Sheikh Saeed Hall 2, booth no. S2G30
www.maquet.com
Maquet – A Full Solution Provider
For more than 175 years, Maquet product development has been
rooted in real-world needs, as part of a close cooperation with clinicians and scientists around the world. This collaboration enables
Maquet to develop comprehensive clinical solutions and set new
standards that address specific therapeutic needs.
Sustainable Solutions for Growth
Long term, sustainable solutions are needed to address evolving
health markets and increasing budgetary concerns across the globe.
Today, products are no longer just evaluated according to clinical
relevance, but also according to return on investment. Operating
rooms and the processes associated with them are an essential
return factor for hospitals.
Every improvement in surgical workflow process is not just a benefit
for patients, but also makes economic sense for the hospital as resources are used more effectively.
Maquet | The Gold Standard
Visit us in Sheikh Saeed Hall 2, booth no. S2G30
www.maquet.com